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Atopic dermatitis (AD), commonly known as eczema, is a chronic itchy skin 
condition with an increase incidence of occurrence at skin folds. It manifests 
due to a complex interplay of genetic and environmental factors. The 
increasing prevalence in industrialised countries such as Singapore has made 
AD an important health problem worth researching. With this in view, we 
embarked on a journey; (i) to conduct an epidemiological study for identifying 
and evaluating risk factors associated with eczema in Singapore, (ii) to screen 
and validate associations of epidermal barrier-related genes to AD in ethnic 
Chinese of Singapore, (iii) to functionally characterise CA6, a gene found 
associated with the maximum number of tags and (iv) to replicate previously 
reported associations in ethnic Chinese. 
Our epidemiological study compared to the previously conducted two studies, 
showed an increase in prevalence of chronic rash at skin flexures to 15.7% 
compared to 10%  in 2001(Wang et al., 2004) and 6.5% in 1994 (Goh et al., 
1996) . There has also been an overall increase in self reported eczema. The 
steep increase in prevalence is indicative of non-genetic (environmental) 
contributing factors its pathogenesis in Singapore. This study identified 
demographic variables such as gender, race and age to be associated with 
eczema, with females, Malays and older age group reporting a higher 
prevalence. Paternal eczema was found to be the most highly associated 
[adjusted OR = 3.68 (2.91-4.67, 95% CI), P< 0.001], followed by eczema in 
both parents [adjusted OR = 3.31 (1.91-5..767, 95% CI), P< 0.001] confirming 
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the strong genetic link. Atopy, diet choices and sedentary lifestyle were also 
found associated after controlling for the demographic confounders.  
The strongest association to parental history justified a genetic study based on 
which a case-control genetic association study was initiated. Candidate genes 
selected on the basis of the barrier dysfunction hypothesis went through a two-
stage analyses using Illumina's BeadXpress platform, which validated 
association of 27 genes. The gene with the maximum number of representative 
SNPs associated with AD i.e., carbonic anhydrase VI (CA6) was selected for 
further functional characterisation. 
Gene expression and selective exon expression were evaluated for the 
associated SNPs of CA6 using Affymetrix's Human Exon ST1.0 array. To 
evaluated the regulatory effect of methylation, we used Illumina's Infinium 
HumanMethylation450 BeadChip. SNPs from CA6 were found associated 
with gene expression and selective exon expressions indicating alternative 
splicing. The SNPs were also found to be associated with methylation-
regulated gene expression and alternative splicing. These ex vivo results 
prompted us to confirm the findings in vitro, experiments for which are under-
way. Association was also found to skin pH when compared to one of the 
significant SNPs suggesting the function of CA6 in pH maintenance. As 
explained in great details in the thesis, pH regulates the fine balance of skin 
shedding (desquamation), an aberration in which can compromise the integrity 
of the skin making an atopic person susceptible to AD. As maintenance of pH 
is crucial to the maintenance of homeostasis in the epidermis, CA6 may play a 
crucial role in the manifestation of AD. This necessitates further research for 
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understanding the less-known CA6 in the context of skin and further 
characterisation of the changes caused by the associated variants. 
Simultaneously, we also undertook replication studies for well known 
associations reported in ethnic Chinese. The SNPs found associated through a 
genome-wide association study in Han Chinese were replicated in our 
Singapore cohort, resulting in a paper. Also, the recently found diverse 
landscape of Filaggrin (FLG) mutations in Singapore Chinese was tested for 
association to AD. We found the common variants of FLG  associated with the 
more severe and chronic forms of AD in our cohort. 
Overall, this thesis identifies important epidemiological and genetic factors 
associated with AD. The findings of this thesis pave way for further research 
of the associated genes, especially highlighting the novel CA6, which maybe 
the silver bullet for AD. Although still in the initial stages of evaluating CA6's 
contribution to AD, this thesis has laid the ground-work for more focussed 
basic, diagnostic and therapeutic research. 
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Chapter 1  
 
Introduction to Atopic Dermatitis 
 
"I have approximate answers and possible beliefs, 
in different degrees of certainty, about different things.  
But I'm not absolutely sure of anything." 
-Richard Phillips Feynman 
1.1 Atopic Dermatitis 
Atopic dermatitis (AD) is one of the three classical allergic diseases (asthma, 
allergic rhinitis and AD) widely studied. AD commonly known as eczema is a 
relapsing inflammatory skin condition with a predisposition for skin flexures 
(Williams, 2005). Typical symptoms include xerosis (dryness), pruritus (itch), 
and erythematous lesions with increased trans-epidermal water loss (TEWL) 
(Cork et al., 2009). The ‘World Allergy Organisation’ (WAO) in 2003 revised 
allergy-related nomenclature and termed eczema as an umbrella term for 
dermatitis with certain common clinical characteristics involving genetically 
determined skin barrier defect. It also added that only if the affected person is 
atopic—which may be concluded by measuring immunoglobulin E (IgE) 
levels or performing a skin prick test, only then the disease may be termed as 
atopic eczema (Johansson et al., 2004) or atopic dermatitis. Although not a 
debilitating disease, AD still has a considerable impact on the patients and 
their families in terms of quality-of-life and economic burden (Akdis et al., 
2006; Delea et al., 2007) 
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1.2 Clinical phenotype 
Clinical presentation of AD differs with age and the course of the disease. 
Eczematous lesions may be present in acute (oozing, crusted vesicles, 
erythematous plaques), subacute (thick and excoriated plaques) or chronic 
(lichenified, pigmented, excoriated plaques) forms. The clinical features of 
AD during infancy are papulo-vesicular eczematous lesions, mainly present on 
the cheeks, scalp and other exposed areas. During childhood the flexural areas 
(ante-cubital fossae, neck wrist, etc), nape of the neck, dorsum of feet and 
hands get affected while in the adolescent and adult stages lichenified plaques 
may affect the flexures and neck areas with itch being associated at all 3 stages 
(Bieber, 2010). 
1.3 Prevalence 
AD is an early onset disease with over 70% of cases starting under 5 years of 
age and around 10% reported to start in adulthood (Williams, 2005). Studies 
have reported childhood prevalence of AD in Europe to be around 10-15% 
with a persistence rate of 40-60% post puberty (Wüthrich, 2006). It has a high 
prevalence rate in developed countries like UK (19.5%), Denmark (22.9%), 
Hong Kong (20.1%), and Japan (19%) (Tay et al., 2002). According to the 
International Study of Asthma and Allergies in Childhood (ISAAC), the 
prevalence varies from less than 2 percent in Iran and China to approximately 
20 percent in Australia, Scandinavia and United States (Williams, 2005). 
Surveys conducted in over 30 schools in Singapore in 1994 showed the 
prevalence of AD with flexural involvement at 6.9% (Goh et al., 1996) which 
grew to 10.2% in 2001. Amongst the three allergic diseases evaluated, AD 
was the only one to show a significant increase within 7 years (Wang et al., 
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2004). In a different cross-sectional epidemiological study, the one year 
prevalence of eczema in Singapore was reported at 20.8% (Tay et al., 2002). 
The reported steep increase in prevalence and severity of AD in the 
Singapore population motivated us to comprehensively study and analyse 
this disease in the Singapore context. 
1.4 Causes 
AD like many other allergic diseases has a genetic predisposition. Population 
studies done in Avon county, England showed a strong association between 
parental eczema and childhood AD with an odds ratio of 2.72 (95% CI: 2.09 to 
3.53) when both parents are affected and odds of 1.7 (95% CI: 1.4 to 2.0) with 
1 affected parent (Wadonda-Kabondo, 2004). Twin studies reporting 
concordance rates of 0.72 - 0.86 in monozygotic and 0.21 - 0.23 in dizygotic 
twins further confirmed the genetic contribution to the disease (Schultz 
Larsen, 1993; Thomsen et al., 2007). However, genetics alone cannot explain 
the results of migrant-population studies which show Jamaican children living 
in London are twice as likely to develop AD as Jamaican children living in 
Jamaica or the increased risk of AD in smaller families and higher social 
classes or its rising prevalence in some countries (Williams, 2005). 
Epidemiological data from Northern Europe has shown a 5-10 fold increase in 
prevalence rate over four decades reaching a staggering 20% (Schultz Larsen 
et al., 1996; Schultz Larsen and Hanifin, 1992). Similarly, the prevalence of 
AD in Swedish schoolchildren has more than doubled between 1979 and 1991 
(Broberg et al., 2000). Similar trend observed in Singapore elucidates the 
importance of environmental factors such as allergens e.g. house-dust mites, 
food, etc in mediating AD expression. Non-allergic factors such as rough 
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clothing, Staphylococcus aureus infections, exposure to microbes during 
infancy, excessive heat, and exposure to irritants that disrupt the function of 
the skin barrier may also be important in disease causation (Williams, 2005). 
Also, adding to the complexity are ethnic variations. Epidemiological surveys 
conducted in Singapore and Malaysia showed a higher prevalence of AD in 
Chinese and Malays as compared to Indians (Tay et al., 2002). This is 
attributed to the ethnic differences, due to which one interacts differently with 
a given environment leading to differences in disease expression. These and 
many more studies indicate AD as a highly complex disease which involves 
a complex interplay of genetic and environmental factors in disease 
manifestation. 
1.5 Different pathogenic models 
Atopic dermatitis as the name suggests, has largely been considered an atopic 
disorder. Atopy as defined by WAO is a personal and/or familial tendency, 
usually in childhood or adolescence, to become sensitized and produce IgE 
antibodies in response to ordinary exposures to allergens, usually proteins 
(Johansson et al., 2004). Also, diagnosis of AD in early childhood is 
considered the start of an ‘atopic march’ as most of these children later 
develop asthma and/or other allergic disorders (Kraft et al., 1998). This 
suggests that AD manifests because of an immunological dysfunction which 
entails a dominant Th2 pathway, brief mechanism of which is explained 
below. 
Manifestation of type-1 allergic hypersensitivity reaction is a complex 
pathway involving the Th2 pathway and IgE. The primary exposure known as 
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sensitisation occurs when an innocuous allergen enters the skin and is 
internalised by antigen presenting cells (APCs), which are present in the skin. 
After digestion and processing into its constitutive peptides, the antigen are 
presented via major histocompatibility complex class II on APC's cell surface. 
These APCs then migrate and present the antigen to the naive T cells which 
leads to the maturation of the T cell. The milieu in which the T cells mature 
shifts the balance to either Th1 or Th2 pathway, which depends on the type of 
APC presenting the antigen and the genetic predisposition of an individual. An 
environment of interleukin (IL) 4 (IL4) and IL10 tips the balance to Th2. 
Following this polarisation, the mature T cells then secrete the various Th2 
cytokines including IL3, IL4, IL5, IL9, IL13. This cocktail of cytokines and 
co-stimulatory molecules  recruits and class switches B cells to start producing 
IgE antibodies. These IgE molecules circulate and bind to high affinity 
receptors on the resident mast cells of the skin epithelium. Upon the 
subsequent exposure of the same allergen, the antigens are recognised by the 
IgE armed mast cells leading to cross-linking and de-granulation of the mast 
cells spilling the contents like histamine, leukotrienes, super-oxides amongst 
others leading to inflammatory reaction and tissue damage (Galli et al., 2008). 
The above described atopic reaction on the skin with elevated IgE levels 
leading to skin cell disruption as a fallout of inflammation was long thought to 
be the causative mechanism for AD. 
A possible autoimmune role of IgE targeting epithelia in AD has also been 
suggested (Valenta et al., 1998). Auto-allergy can be mediated through either 
(i) cross-linking of cell bound IgE antibodies by auto-allergens leading to 
release of inflammatory mediators, or (ii) IgE mediated auto-allergen 
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presentation activating auto-reactive T cells to release pro-inflammatory 
cytokines, contributing to lesions forming AD (Valenta and R., 2000).  
Also, different studies indicate that immune-hyper-reactivity isn’t present in 
all AD patients with over 50% of cases not showing elevated levels of IgE up 
to age 2 (Illi et al., 2004). However, eventually 80% of these non-atopic 
patients (intrinsic AD) eventually turn atopic (extrinsic AD) indicating a non-
immune aetiology as the primary event in AD (Cork et al., 2009). Not all 
children with AD develop the other diseases in the atopic march suggests that 
elevated IgE levels alone may not be responsible for AD (Kraft et al., 1998). 
Thus, IgE, a marker for T-cell dysregulation towards the production of Th2 
cytokines, is at best associated with atopic status and not causative of lesions 
on target organs like skin (Taieb, 1999). Validation of this claim was further 
strengthened by a meta-analysis study showing a strong association of atopy to 
disease severity rather than to just AD (Flohr et al., 2004).  
Many studies have shown AD severity paralleling permeability barrier 
abnormalities (Angelova-Fischer et al., 2005; Seidenari and Giusti, 1995; 
Sugarman et al., 2003). Also different groups have shown both clinically 
uninvolved skin sites and skin cleared of inflammation for as long as 5 years 
continue to display significant barrier abnormalities (Eberlein-Konig et al., 
2000; Seidenari and Giusti, 1995). Barrier maintenance and restoration 
through emollient therapy and lipid replenishing creams have shown 
corrective measures against barrier abnormality along with site inflammation 
for AD (Cork et al., 2003; Elias et al., 2008). 
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The gaps identified with the atopic pathogenic model in the early 1990s led 
Hideoki Ogawa to propose a paradigm shifting hypothesis in his 15
th
 Annual 
Meeting of Japanese Society for Investigative Dermatology address. He was 
the very first to hypothesize the importance of a dysfunctional epidermal 
barrier as the primary event in the pathogenesis of AD. He along with 
Takashi Yoshiike was the first to publish this alternative hypothesis 
integrating barrier dysfunction and atopy as key players to the pathogenesis of 
AD (Ogawa and Yoshiike, 1993). Following this, Alain Taeib and others 
started describing AD in this new perspective which lead to a wider 
acceptance of this alternative theory (Taieb, 1999).  Reports showing reduced 
levels of — ceramides that hold the cells together (Imokawa et al., 1991), 
filaggrin which helps retain moisture (Seguchi et al., 1996), transepidermal 
water loss which indicates penetrability of the skin (Loden, 1995) further 
corroborated the innate defect of the epidermal skin barrier as the primary 
event rather than an epiphenomenon in the pathogenesis of AD. 
1.6 Skin as a barrier 
Skin is the largest organ separating us from the environment. It forms the first 
line of innate defence by providing not just a physical but also a complex 
chemical and biological barrier. These defensive functions include: the 
permeability barrier which retards trans-cutaneous evaporative water loss— 
allowing survival in a desiccating external environment; antimicrobial barrier 
which resists growth of microbial pathogens by encouraging colonization by 
non-pathogenic ‘normal’ flora (Elias and Schmuth, 2009). Thus, an intact-
uncompromised epidermis is a prerequisite for the skin to function as a barrier. 
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Maintaining the integrity of the epidermis is a very complex process which 
involves a well regulated squamation (new cell growth) and desquamation 
(shedding) process for maintaining homeostasis. A flaw in any of the 
mechanisms maintaining the integrity can lead to a compromised epidermis. 
This compromised state can be an entry point for allergens and pathogens 
which can elicit an immune response leading to AD. To understand the barrier 
we first need to look at the skin and understand its maintenance. 
 
Figure 1-1: Different layers of skin involved in barrier maintenance 
Adapted from (Cork et al., 2006) 
 
 
The epithelium consists of layers of stratum corneum (SC) on the outer side 
followed by stratum granulosum (SG), stratum spinosum and stratum basale 
on the inside when observed transversely. The barrier for irritants and 
allergens is located in the SC. In humans the SC has an average of 20 
corneocyte layers, with each corneocyte being approximately 30 µm in 
diameter. Corneocytes are flattened anucleate, organelle-less cells consisting 
of densely packed keratin fibers. These cells represent the final differentiated 
stage of the keratinocytes originating from the granular layer (Cork et al., 
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2006). The thickness of the SC varies within body regions, being thicker to 
protect areas subjected to greater friction (Lee and Hwang, 2002).  
 
 
Figure 1-2: Brick wall model of the stratum corneum. 
(Adapted from Elias, 1983 & Cork et al, 2006) 
 
As depicted in figure 1.2, the corneocytes are held together by modified 
desmosomes called corneodesmosomes. Corneodesmosomes help in providing 
structural integrity and tensile strength to the SC for resisting shearing forces. 
Elias et al visualized the SC as a brick wall, with the corneocytes being the 
bricks which are cemented by the extra-cellular lipid lamellae (Elias, 1983). 
Cork et al extended this model by envisioning the corneodesmosomes 
analogous to iron rods that pass down though holes in the bricks to give the 
wall its tensile strength (Cork et al., 2006). During the formation of 
corneocytes, the granular cells spill out their lamellar granules by secreting a 
unique organelle, the epidermal lamellar body (LB), which contains lipid 
constituents (e.g. cholesterol), lipid precursors (e.g. glucosylceramides and 
phospholipids), enzymes (e.g. β-glucocerebrosidase, acidic sphingomyelinase, 
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and secretory phospholipase A2) required for generating ceramides and free 
fatty acids (FFAs). The lipid lamellae (cement) prevent water loss and 
penetration of water-soluble materials. Besides, making the barrier as tight as 
possible they also provide flexibility. The process of keratinocyte 
differentiation which originates at the stratum basale layer and continues to the 
corneocyte in the SC is regulated by many proteases and their inhibitors which 
are also contained in the LB. This cocktail of serine, aspartic and cysteine 
proteases and their inhibitors orchestrate the orderly digestion of 
corneodesmosomes and transient intercellular junctions which allows 
corneocytes to be shed invisibly from the skin surface, a process called 
desquamation. Desquamation treads a fine balance between adequate 
breakdown of the barrier to allow a continual renewal of epidermal cells and 
leaving the barrier sufficiently intact to prevent allergens and irritants from 
gaining access to the deeper layers of the skin (Elias et al., 2008). 
An aberration in squamation and desquamation process can lead to a 
compromised barrier predisposing an individual to AD (Figure 1.2). Besides a 
dysregulated physiological processes of skin/ barrier maintenance, sustained 
psychologic stress also aggravates the permeability barrier dysfunction. 
Psychological stress is both a well-known cause of AD and a cause of 
resistance to therapy. In experimental animals psychologic stress induces an 
increase in endogenous glucocorticoids which inhibit the synthesis of the three 
key epidermal lipids that mediate barrier function, i.e., ceramides, cholesterol, 
and FFAs (Elias et al., 2008).  
The skin’s barrier is further safeguarded by a variety of antimicrobial agents 
and peptides secreted either by the lamellar bodies or in the sweat glands. A 
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host of antimicrobial peptides (AMPs) have been identified on the skin such as 
β-defensins, cathelicidins, dermcidins, lactotransferrin, lysozymes, RNase7, 
amongst others that are permeability increasing proteins thereby exerting 
bactericidal effect (Schauber and Gallo, 2009). FFA and sphingosines also 
exhibit antimicrobial activities. Some of these are either constitutively 
expressed whereas some are inducible by bacterial infections and cytokines. 
They have a broad spectrum effect covering gram positive, gram negative 
bacteria, fungi and viruses. Most of the AMPs also have a pro-inflammatory 
effect making them an active component of innate and adaptive immunity 
(Hata and Gallo, 2008). 
AD is frequently associated with recurrent bacterial and viral infections with 
over 90% of lesions and 76% on unaffected skin being colonised by S. aureus 
as compared to around 5% in healthy controls (Schittek et al., 2008). Studies 
have shown a significant reduced expression levels of AMPs in AD skin as 
compared to psoriatic skin which is another barrier dysfunctional disorder. 
The reduced levels of AMPs in combination with scratching further 
compromises the barrier property of the skin thereby allowing S. aureus and 
viruses such as HSV to bind and proliferate (Hata and Gallo, 2008). 
1.7 Filaggrin in AD 
An important gene, widely and most strongly associated with AD is Filaggrin 
(FLG). FLG is one of twenty-plus proteins which gets incorporated in the 
tough, insoluble layer of the corneocytes (Candi et al., 2005; Oregan et al., 
2008). It plays a role in aggregating keratin fibers of the cellular cytoskeleton 
into bundles, thereby collapsing the corneocytes into flattened discs with a 
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large surface area. FLG is also extensively deaminated through the actions of 
the enzyme peptidyl deiminase and subsequently degraded into free amino 
acids which are then catabolized into the constituents of natural moisturizing 
factor (NMF), such as lactic acid, sodium pyrrolidone carboxylic acid, 
urocanic acid, and urea. NMFs are essential for water retention within 
corneocytes resulting in their optimal hydration and swelling, which prevents 
the development of gaps thereby enhancing the integrity of the SC and making 
it resistant to the penetration of irritants and allergens (Elias et al., 2008).  
Although initially widely studied in association with ichthyosis vulgaris (IV), 
it's association to AD was shown in a subset of the IV families and later 
validated in different European populations (Palmer et al., 2006). Of the many 
mutations reported, two most common loss-of-function mutations (R501X and 
2282del4) account for the majority of AD cases. Up to 50% of AD individuals 
with European ancestry reveal single- or double-allele or compound mutations 
in FLG (Elias et al., 2008). Subsequently, FLG's association was validated in 
many different studies such as in a German study on 3000 children  
(P=2.5×10
-14
, odds ratio 3.12) (Weidinger et al., 2008). A 1-bp deletion 
5303delA in mouse Flg analogous to common human FLG mutations results 
in increased allergen priming, cutaneous inflammation and elevated IgE levels 
against the test allergen, supporting the barrier dysfunction hypothesis (Fallon 
et al., 2009). In the Japanese population as well, FLG has been shown 
associated with AD, however, a different profile of FLG markers seems to 
exist in different populations (Osawa et al., 2010). FLG's wider variant 
landscape was further highlighted with an exhaustive discovery search in the 
Singapore Chinese population where 22 null mutations, 14 of which were 
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novel, were discovered. Different combination of these 22 null mutations were 
reported to be associated with AD (Chen et al., 2011). 
1.8 AD: a complex disease 
AD is a polygenic disease of low penetrance but has a higher prevalence than 
other monogenic diseases. Similar to other non-Mendelian diseases, AD is 
multi-factorial with several different (atopic and barrier dysfunction) genetic 
mechanisms interacting with different environmental factors in different 
people (Kluken et al., 2003).  
 
With a significant socio-economic impact and increasing prevalence, AD is a 
viable research candidate. The variability in genes reported for different 
populations under the influence of different environments makes researching 
AD in a niche-like setting such as that of Singapore all the more crucial for its 
better understanding.  
Figure 1-3: Working hypothesis of AD pathogenesis. 
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1.9 Objectives  
 
With this background information and the working hypothesis of AD 
manifestation as shown in Figure 1.2, following are the aims of this thesis: 
1. To conduct an epidemiological study for identifying and evaluating 
risk factors associated with eczema in Singapore. 
2. To screen and validate barrier maintaining genes associated with AD in 
ethnic Chinese of Singapore. 
3. Using an associated gene, evaluate the effect of the risk variant on 
gene function. 





Chapter 2  
 
Epidemiology of eczema in Singapore 
 
2.1 Introduction 
With the need for better understanding the global epidemiology of allergic 
diseases, International Study of Asthma and Allergies in Childhood (ISAAC) 
investigated the worldwide prevalence with their standardised questionnaire. 
This massive effort was undertaken in over 56 countries across multiple 
centres in each country. With their phase one, they found a wide variation in 
prevalence of asthma, allergic rhinitis and eczema across the globe 
(Committee, 1998). The wide variation further highlighted that regional 
differences, accounted for by different genetic background and environment, 
contribute to the disease phenotype. Thus, for a deeper understanding of the 
disease by generating new hypotheses and evaluating the existing hypotheses, 
a systematic epidemiological analyses in a given geographical context 
becomes crucial. 
In this chapter, I will be describing the study undertaken to evaluate the risk 
factors for eczema in Singapore in an epidemiological setting.  
 
2.2 Materials and methods: 
 




Population was ascertained using a cross-sectional sampling methodology 
from National University of Singapore's (NUS) campus. The recruitment 
drives targeted undergraduate and graduate students and staff from all faculties 
on campus above 18years of age. The sample recruitment drives were 
organised every year for over seven years and is still being continued. The 
recruitment drives were approved by the Institutional Review Board (NUS-
IRB Reference Code: 07-023 and NUS10-343) and were in accordance with 
the Helsinki Declaration. All participants recruited in NUS were compensated 
for their participation in the study with S$10 vouchers. 
Participants were also tested for their atopic status by performing a skin prick 
test (SPT). The participants were tested for four aeroallergens namely 
Dermatophagoides pteronyssinus, Blomia tropicalis, Elaeis guineensis and  
Curvularia lunata. To validate the test, a positive and negative control i.e. 
histamine and saline (buffer used for the preparation of the allergen) 
respectively were also skin pricked. SPT was considered positive when the 
wheal diameter was ≥ 3mm whereas no signs of wheal and erythema was 
considered a negative SPT. Participants with less than 3mm reaction for 
histamine or, an erythema or wheal to saline, or smaller than 3mm reaction to 
the test allergens were not considered for analyses. Studies done by the lab 
previously showed that skin-prick reactivity to dust mites especially the two 
species Blomia tropicalis and Dermatophagoides pteronyssinus were highly 
sensitive and  specific markers for allergic sensitization in Singapore (Chew et 
al., 1999). Thus, together with the positive and negative controls, a positive 
reaction to either of the dust mites indicated positive SPT or atopy. 
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2.2.2 Classification and disease definitions 
For disease classification participants filled out the standardised and validated 
ISAAC questionnaire (Asher et al., 1995). Core questions of ISAAC provided 
information on current (last 1 year) and past symptoms for asthma, allergic 
rhinitis (AR) and eczema.  The questionnaire also had sections for 
demographic, medical, dietary, lifestyle and family information. Additional 
question from other UK working party criteria (Williams et al., 1994a) on dry 
skin was added at a later stage of the collection. The complete questionnaire is 
attached in the appendix. 
A participant was categorised as a case for eczema if he or she answered 
affirmative to "ever had itchy rash" and "rash at skin flexures". Based on UK 
working party's criteria, flexural involvement of rashes had 90% sensitivity 
and 75% specificity for diagnosing AD (Williams et al., 1994a).  
2.2.3 Associations with eczema 
All the queried independent variables in the questionnaire were test for 
association to eczema. The list was exhaustive based on the questionnaire. 
Categorical variables were analysed for the dichotomous disease outcome. 
Continuous variables such as age and number of years in Singapore were split 
into groups and coded categorically. Associations were checked individually 
for each independent variable giving odds ratio (OR) and their respective 95% 
confidence interval (95% CI) and were considered significant if the p value 
was less than 0.05 and odds ratio range did not cross 1. Independent variables 
were also re-tested adjusting for associated demographic factors such as 
gender, age group, race. This was done to control for any false positives 
arising due to the confounding effect of demographics on disease outcome. 
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2.2.4 Statistical Analyses: 
All data entry and statistical analyses were done using Microsoft Excel 
(http://office.microsoft.com/en-us/excel/) and SPSS 
(http://www.ibm.com/software/analytics/spss/). The binary logistic regression 




2.3.1 Population description 
As the collection was at the university campus, we obtained a large diversity 
in ages participating. However, for this analysis the age groups considered is 
from 18 to 32, subjects above 32 years of age were excluded. After excluding 
samples not matching our age band, we obtained 8334 samples as shown in 
Table 2.1. The male to female ratio were almost similar. The age groupings 
were done to avoid any skews towards a group with around 36% of the 
population between the 18-20 and 20.01-22 age groups. The pre-dominance of 
ethnic Chinese in Singapore's population resulted in 91% of samples recruited 
to be ethnic Chinese, followed by 4% Indians, 2% Malays and the remaining 
were either of mixed heritage or from other races. As shown in Table 2.1, 
close to 63% lived in flats provided at subsidy by the Singapore government,  
around 17% in condominiums and around 13% in landed property. Monthly 
family income in Singapore dollars did not reveal a wide difference between 
the 4 classes. Singapore's diverse background is evident by the proportion of 
participants born in countries other than Singapore. The international student 
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community accounted for the 20% of population living in Singapore for less 
than 5 years. 
Variables Number  (%) 
Gender 
   
 
Male 3615 (43.38) 
 
Female 4707 (56.48) 
 




18-20 3074 (36.89) 
 
20.01-22 3048 (36.57) 
 




Chinese 7565 (90.77) 
 
Malay 158 (1.90) 
 
Indians 331 (3.97) 
 
Others 280 (3.36) 
Housing 
   
 
Public flats 5261 (63.13) 
 
Private apartments 1433 (17.19) 
 
Landed property 1137 (13.64) 
 
Not stated 503 (6.04) 
Family income (S$/month) 
 
 
Less than 2000 2075 (24.90) 
 
2000-3999 2858 (34.29) 
 
4000-5999 1493 (17.91) 
 
6000 and above 1579 (18.95) 
 
Not stated 329 (3.95) 
Country of birth 
  
 
Singapore 5517 (66.20) 
 
Others 2781 (33.37) 
 
Not stated 36 (0.43) 
No. of years in SG 
  
 
0-5 1691 (20.29) 
 
5.01-10 420 (5.04) 
 
10.01-32 5891 (70.69) 
 
Not stated 332 (3.98) 
Total studied 8334 (100) 
 
Table 2-1:  Demographic profile and socioeconomic categories of study 
population. 




2.3.2 Self-reported prevalence of asthma, allergic rhinitis and eczema 
The response rates for all three-disease sections of the questionnaire were high 
with asthma section being responded by 100%, allergic rhinitis (AR) by 
99.74% and AD by 99.72% of the participants (Table 2.2).  
Five percent of the asthma respondents reported wheezing in the last one year 
with 18% reporting in positive to the question "ever had wheezing?" 
indicating that most of them had childhood asthma. The response to the 
question "ever had wheezing?” (‘ever wheezing’) had a higher positive 
response from males as compared to females and it correlated well with self 
diagnosed asthma. Self diagnosed asthma was queried by the question 'have  
you ever had asthma'  coded as 'ever asthma'. Stratification based on races 
indicated that Indians followed by Malays showed higher prevalence of 
wheezing in the last one year and wheezing during exercising. However, only 
16% of Indians self-reported asthma as compared to 23% Malays indicating 
lack of awareness. With respect to family income, a trend of increasing 
prevalence of asthma symptoms was observed with increasing family income.  
It was also found that wheezing and self reported asthma were reported higher 
amongst people born in Singapore. 
The trend of growing out of allergic diseases wasn't observed in AR with 51% 
reporting AR in the past one-year and a total of 56% reporting in positive to 
ever having it. When stratified with respect to gender it was seen that males 
had a higher percentage of self-reporting AR as compared to females. Allergic 
rhinitis had an equal spread amongst the races except for the higher prevalence 
of self reported AR in the Chinese as compared to Malays. It was also 
observed that the people born in Singapore and those who had spent 10.01-32 
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years in Singapore had a higher prevalence of AR within the last one year as 
compared to people born in other countries.  
The percentage of participants reporting in positive to ever having a rash was 
similarly distributed to the ones who had a chronic rash in the past one year. 
Eighteen percent of the respondents claimed to have flexural rash which is a 
hallmark of AD, whereas only 13% reported the presence of eczema indicating 
an under diagnosis of the disease. With respect to gender, females reported a 
higher incidence of chronic rash at flexures. Race stratification showed that as 
compared to the Indians and Chinese the Malays had the highest prevalence 
for eczema related symptoms. It was also observed that people born in 
Singapore and those who had spent 10.01-32 years in Singapore had a higher 







2.3.3 Self-reported prevalence of severity of asthma, allergic rhinitis and 
eczema. 
Severity of the three allergic diseases was evaluated for those who reported 
symptoms in the last one year (Table 2.3).  
Of the asthma respondents having wheezing in the last one year, 70% of them 
had 1-3 wheezing episodes, 21% had 4-12 episodes and about 5% had more 
than 12 episodes of wheezing averaging more than once a month in the past 
year. While the majority of the current wheezers seemed to have mild asthma 
not causing sleep disturbance (61%), 10.5% suffered wheezing strong enough 
to be woken up form sleep more than 1 night per week and close to 12% 
reporting speech limitation due to wheezing. The stratification based on 
gender showed no particular bias with the exception of speech limitation 
wherein females reported twice as more prevalent than in males (8%). Based 
on age group our data showed a higher prevalence (27%) of 4-12 wheezing 
attacks in the 20.01-22 age band. The oldest age group reported higher 
prevalence of no interference with daily activities as compared to the other 
two age groups. Unfortunately, the stratification based on race for asthma 
severity cannot be commented as only 11 Malays reported wheezing in the last 
one year and percentages calculated off this number could be unreliable. 
Based on housing our data showed a trend of higher prevalence of severity of 
asthma in private housing as compared to public or landed. Symptoms such as 
higher frequency of wheezing attacks and speech limitation did show a trend 
of increased prevalence in the more affluent families (15% versus 7%). 
Amongst the sufferers with AR symptoms in the past one-year, majority 
(37%) reported mild interference with daily activities and close to 3% reported 
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severe interference. Twenty-five percent found their AR symptoms 
troublesome with 22% reporting sleep disturbance. Largest proportion (29%) 
has been living with AR symptoms since more than 10 years. Of these a 
higher proportion of males are reported to be living with AR symptoms for 
more than 10 years (33%). Based on race, Indians reported to have higher 
prevalence of interference of daily activities and disturbances due to AR 
symptoms. Severity of rhinitis did not seem to fluctuate much, when binned 
according to type of housing. Also the severity symptoms showed no changes 
when compared across the four income groups. People living with AR 
symptoms for the past 1-4 years was highest amongst the group of people 
staying in Singapore for 5.01-10 years (31%) followed by 0-5 years (24%) and 
was least in people staying for more than 10 years (17%). 
Close to 50% of the respondents claiming chronic rash in the past one year 
reported the rash occurring first above the age of 5. Thirty-four percent of 
them reported persistence rash with the rash not completely clearing up in the 
past one year. Severity measured by being kept awake due to rash showed 
60% of mild form to 10% of the severe form. Question on dry skin was 
incorporated in the questionnaire much later in the collection years. This 
resulted in the number of respondents with chronic rash, which encountered 
the question on dry skin as 793. Of the 793 individuals, 52% reported to have 
dry skin. Of these females were reported higher at 57% as compared to 43% 
males. A trend of decreasing severity of eczema was reported with the 
increase in age. Stratification based on race showed that Malays have a higher 
prevalence of persistent rash in the past year followed by Chinese, with 
Indians reporting the least prevalence of such a persistent rash. Malays again 
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reported a higher prevalence of dry skin as compared to the other two races. 
The data showed no variations depending on the type of housing, but showed a 
higher prevalence of early onset eczema and more severe symptoms disturbing 
sleep in the highest income slab group. People living in Singapore for more 
than 10 years had a higher prevalence of dry skin (57%) and more severe form 
of eczema (11%) as compared to those staying for less than 5 years (43% and 
5% respectively). 
The gender ratio for asthma and AR were similar, however, there were close 
to twice the number of females who reported eczema in the last 1 year. The 
higher age group of 22.01- 32 years showed to have a lower prevalence for all 
three diseases. The racial distribution of all the diseases was similar to the 
racial distribution in the population with the exception of Indians having 
higher self-reported wheezing in the last one year. The distribution with 
regards to the type of housing, family income, country of birth and years in 







2.3.4 Association of covariates 
2.3.4.1 Evaluation association of demographics to eczema 
Demographic factors such as gender, age, race, housing, monthly family 
income, country of birth and number of years in Singapore were tested for 
association to eczema. Eczema was defined as chronic rash having a flexural  
involvement which made up to 1310 individuals from the 8334 ascertained, 
bringing its prevalence to 15.72 %. Continuous data such as age and number 
of years in Singapore were categorised into three groups as shown in the 
above tables. Logistic regression for outcome of disease was used to obtain 
Table 2.4. 
Table 2.4 shows that females had a higher odds of having eczema as compared 
to males (OR 1.23). Age group also showed mild association with the more 
older group having a higher prevalence of eczema (OR1.16) as compared to 
the other 2 age groups. Race also showed a disparity with Malays having 
higher odds of developing eczema as compared to Indians. No associations 
were found at the housing, family income, country of birth and years spent in 
Singapore to the disease outcome. 
As demographics such as gender, age group and race were associated with 
eczema, analyses for other variables may be confounded by their effect. 
Hence, the following variables - gender, age and race were used for adjusting 








Categorical variables Odds ratio  (95% CI) p value 
Gender 
   Male Ref NA NA 
Female 1.23 (1.09-1.39) 0.001 
Age group 
   20.01-22 Ref NA NA 
18-20 1.16 (0.94-1.24) 0.271 
22.01-32 1.16 (1.00-1.35) 0.042 
Race 
   Indian Ref NA NA 
Chinese 1.39 (0.99-1.96) 0.054 
Malay 1.97 (1.18-3.28) 0.009 
Housing 
   Public Ref NA NA 
Private 1.05 (0.90-1.24) 0.485 
Landed 1.04 (0.87-1.24) 0.629 
Family income (S$/month) 
   < 2K Ref NA NA 
2-3.999K 0.95 (0.81-1.11) 0.531 
4-5.999K 0.95 (0.80-1.13) 0.573 
>=6K 0.95 (0.80-1.12) 0.555 
Country of Birth 
   Others Ref NA NA 
Singapore 1.09 (0.96-1.24) 0.159 
Yrs in Singapore 
   10.01-32 Ref NA NA 
0-5 1.01 (0.87-1.17) 0.885 
5.01-10 0.93 (0.71-1.23) 0.656 
        
 
Table 2-4: Association of demographic variables to eczema. 
Abbreviations: CI- confidence interval, Ref- reference, NA- Not applicable, S$- 





Variable Odds ratio (95% CI) p value 
Gender 
   Male Ref NA NA 
Female 1.29 (1.129 - 1.478) <0.001 
Age group 
   20.01-22 Ref NA NA 
18-20 1.01 (0.867 - 1.176) NS 
22.01-32 1.17 (1.003 - 1.364) 0.046 
Race 
   Indian Ref NA NA 
Chinese 1.45 (1.031 - 2.040) 0.033 
Malay 2.06 (1.237 - 3.432) 0.005 
Constant 0.1 NA <0.001 
 
Table 2-5: Demographic variables used for adjusting odds ratio. 
 
 
Table 2-6: Demographics' prevalence odds ratio for eczema. Uni-variate and 
multivariate analyses showing crude and adjusted odds ratio. 
Abbreviations: CI- confidence interval, Ref- reference, NA- Not applicable, S$- 
Singapore dollar, K- $1000, Yrs- years 
 
As shown in the table above, the three variables remain significant even when 
controlling for the presence of the other covariates. Interestingly, when 
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controlling for gender and age, prevalence odds for Malays increases slightly 
and Chinese ethnicity also gets highlighted as a race with significantly higher 
eczema outcome as compared to Indians. 
The demographics earlier found to be not significant were re-evaluated by 
adjusting for the model (Table 2.5) to check for any confounding effect (Table 
2.6). 
After adjusting for the variables, the other demographic variables did not show 
any association. 
2.3.4.2 Evaluating association of diet and lifestyle to eczema 
Questions on diet were also collected and checked for association. Unadjusted 
and adjusted odds ratio for the different diet choices are shown in table 2.7 
below. 
Prevalence of eczema was higher amongst people consuming pulses, nuts, 
potatoes, fast-food and yogurt drinks on most days as compared to people 
consuming it once-to-twice a week. Compared to daily consumption, once-to-
twice a week intake of cereals and rice had a higher prevalence of eczema. 
Participants with occasional consumption of margarine had a higher 





Table 2-7: Diet habit's prevalence odds ratio for eczema. Uni-variate and 
multivariate analyses showing crude  and adjusted odds ratio. 
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Questions on lifestyle such as exercise frequency, sedentary lifestyle, alcohol 
consumption, smoke exposure, pet exposure were asked in the questionnaire. 
In addition, drug allergy information and allergic sensitisation as evaluated by 
skin prick test were also analysed in the following table 2.8. 
 
Table 2-8: Lifestyle, exposure and allergic status evaluated for eczema. Uni-
variate and multivariate analyses showing crude  and adjusted odds ratio. 
 
Physical activity, alcohol consumption, smoke exposure, pet exposure were 
not associated with eczema in this dataset. After adjusting for the three 
demographic variables, sedentary lifestyle of sitting in front of a computer or 
television for more than 5 hours had a higher prevalence of eczema as 
compared to less than 1 hour. Drug allergies queried by a yes or no question 
33 
 
and allergic sensitisation evaluated by positive reaction to dust mites and 
histamine (positive control) showed a strong association to eczema (adjusted 
odds of 1.45 and 1.72 respectively) indicating an atopic background to the 
eczema. 
2.3.4.3 Evaluating association of family background to eczema 
Family background with regards to education and allergic history were also 
evaluated. Table 2.9 summarises mother's background and history as a 
covariate for eczema.  
 
 
Table 2-9: Mother's history evaluated for eczema. Uni-variate and 
multivariate analyses showing crude  and adjusted odds ratio. 
 
Mother's education and asthma status did not show any association to the 
participant's eczema status. However, mother's allergic rhinitis and eczema 
were highly associated (adjusted OR 2.4 and 2.6 respectively) to the 
individual's chances of developing eczema. Although, not a test for risk, the 
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odds ratio approximate the relative risk making mother's eczema a high risk 
factor. If the mother had any allergies (Mother allergy) was evaluated by the 
presence of any of the three queried allergic diseases and it was found to be 
associated, indicating maternal atopic background predisposes an individual to 
develop eczema when compared to no maternal atopy. 
Similar analyses were done for father's education and allergic history as shown 
in table 2.10. 
 
 
Table 2-10: Father's history evaluated for eczema. Uni-variate and ultivariate 
analyses showing crude  and adjusted odds ratio. 
 
There was a higher prevalence of eczema in the group whose father's 
maximum education was until primary as compared to secondary (OR 1.2). 
Father's asthma, AR status affected the individuals odds of having eczema 
(OR 1.6 and 1.9 respectively). Paternal eczema was the most highly associated 
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with the prevalence odds of 3.6 as compared to no paternal eczema. As all 
allergic diseases were associated with the individual's eczema status, 'father 
allergy' calculated as presence of either of the three diseases showed 
association at odds ratio of 2.4. 
To check the combined odds for maternal and paternal effect, data was 
grouped in the same categories as above for disease present in both parents. 
The analyses was done with a reference of not having both parents affected by 
the same allergic disease. Results for the same are tabulated in table 2.11. 
 
Table 2-11: Both parent's atopic history evaluated for eczema. Uni-variate and 
multivariate analyses showing crude  and adjusted odds ratio. 
 
Association to eczema was lost when comparing both parents' asthma and AR 
status. Understandably, parental eczema (OR 3.4) and allergy (OR 2.5) 
remained significant with an odds ratio between the individual parent's odds. 
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Information on number of siblings and number of siblings affected with the 
three allergic diseases were also gathered. Association for number of sibling 
with allergic diseases to eczema status of the individual was evaluated. A final 
combined analyses involving presence of allergic disease in all - mother, 
father and at least one sibling was termed as 'family disease'. Unadjusted and 
adjusted odds ratio for the same confounding variables consisting of gender, 
age and race are tabulated in table 2.12 below. 
 
Table 2-12: Sibling and family's atopic history evaluated for eczema. Uni-
variate and multivariate analyses showing crude  and adjusted odds ratio. 




When comparing siblings affected with asthma, the odds of having eczema 
increased with increase in the number of affected siblings. The same 
increasing trend is not observed with increasing numbers of siblings affected 
with AR although they are still significant. Odds are the highest when the 
siblings also have eczema which doesn't change with change with the number 
of affected siblings. As all three categories are associated, 'sibling allergy' 
categorised as presence of at least one of the diseases versus none, is also 
associated. Family atopic status is also associated with eczema with family 
eczema being the highest (OR 2.8), followed by family AR (OR 1.8) and then 
family asthma (OR 1.4). 
2.3.4.4 Evaluating association of asthma and AR to eczema 
Participant's asthma and AR status were evaluated from the questionnaire. 
They were classified as a case for asthma if they replied positively to "Have 
you ever had asthma?" A participant was classified as a case for AR if they 
had at least two recent symptoms from itchy nose, sneezing, runny or blocked 
nose without having flu. Analysis was also performed for the presence of both 
allergic diseases. Results for the same are tabulated in Table 2.13 on the next 
page. 
Both diseases were associated with eczema, with higher prevalence of AR in 
eczema as compared to asthma. The combined analysis also showed a higher 
prevalence of eczema in people affected with asthma and AR both as 





Table 2-13: Asthma and allergic AR evaluated for eczema. Uni-variate and 
multivariate analyses showing crude  and adjusted odds ratio. 
Abbreviations: AR- allergic rhinitis. 
 
2.4 Discussion 
2.4.1 ISAAC questionnaire 
ISAAC was initiated to describe the prevalence and severity of asthma, 
rhinitis, and eczema in different countries. This was done to obtain baseline 
measurements in order to be able to assess future trends and form a unanimous 
basis for future research. The first diagnostic criteria proposed by Hanifin and 
Rajka (Hanifin and Rajka, 1980) had been widely applied to clinical studies 
but had not been compatible with epidemiological setting. The UK working 
party diagnostic criteria started by British dermatologists had started 
developing and validating diagnosis based on questionnaire data. These 
questions were incorporated into the core questions of the ISAAC 
questionnaire (Asher et al., 1995; ISAAC, 1993). Answering chronic itchy 
rash was used in diagnosis as it helped discriminate the typical mild-moderate 
atopic dermatitis from non-atopic eczema and other dermatological conditions 
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with a 91% sensitivity and around 46% specificity. Whereas the question 
about flexural involvement further enhanced the specificity to 81% and was 
sensitive at 94% (Williams et al., 1994a; Williams et al., 1994b; Williams et 
al., 1994c). 
2.4.2 Disease definition 
According to WAO, 'eczema' is defined as a skin diseases involving a 
genetically determined skin barrier defect. When atopic constitution of the 
dermatitis is dominated by IgE antibodies (measured by either IgE levels or 
skin prick test), then the term or atopic eczema or atopic dermatitis should be 
used (Johansson et al., 2004). As ISAAC is a measure of eczema and prior 
studies in Singapore and other countries are also 'eczema' based, we defined 
our cases for this epidemiological study independent of skin prick results. 
Thus our disease definition for eczema case is someone who has a chronic 
itchy flexural rash. This resulting distinction gave us the opportunity to 
evaluate the association of atopy to eczema. 
2.4.3 Population 
This epidemiological study is a based on a large cohort of 8334 participants 
who fitted our age criteria. The male to female ratio was slightly skewed 
towards the females (56.5%) as the university has a higher population of 
female students. Although Singapore's ethnic composition is around 74% 
Chinese, 13% Malays, 9% Indian (www.singstat.gov.sg), we collected a more 
Chinese heavy cohort with Chinese accounting for 91%, Malays accounting 
for 2% and 4% Indians. The low contribution of Malays can be justified by the 
month we conduct our collection. Our collections are usually in the first two-
three week of the start of semester in August-September around the time of the 
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fasting month. As the collection involves mouth-wash which may involve 
some water being swallowed, Malay students do not readily participate. Other 
demographic variables such as housing and family income had a good spread 
across the different categories. Classification based on country of birth showed 
two- thirds of the cohort to be born in Singapore and about one-third in other 
countries. This is due to the large international student community in the 
university and Singapore. 
2.4.4 Self-reported prevalence of asthma, rhinitis and eczema 
Self reported asthma measures asthma at any stage in one's life, even 
childhood asthma which one might have outgrown. From our data, asthma 
(18.45%) correlated very highly with 'ever wheezing' (18.49%), a hallmark of 
asthma. In 1994, the data presented by an ISAAC study on 6-7 and 12-15 year 
olds in Singapore showed prevalence of asthma at 18.5% and 20.7% 
respectively.  And a later ISAAC done on the same age group in 2001 showed 
prevalence of asthma at 16.3% and 27.4% respectively reporting a significant 
increase in the 12-15 year age groups. However, our data showed the 
prevalence at 18.7%, 20.3% and 15.5% at the 18-20, 20.01-22 and 22.01-32 
age groups. Although a fair comparison is not possible due to the different age 
groups, it can still safely be implied that the prevalence of asthma has reached 
a level of stability in Singapore. The oldest age group showed a reduced 
prevalence of 'ever-asthma' (15.5%), this may be due to a different 
environment when they were growing up as compared to the environment the 
18-22 aged individuals experienced. As compared to the earlier two data sets, 
wheezing in the last year is much lesser at 5% as compared to 13% (1994) and 
10% (2001). This could also be explained by the age difference, as with 
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increasing age most people grow out of asthma. Within our band of 18-32 
years, there did not seem to be much difference as the individuals who grow 
out of asthma had probably grown out by then keeping the prevalence similar 
within the three age groups (Goh et al., 1996; Wang et al., 2004). 
All symptoms for rhinitis showed a drastic increase when comparing to the 
two earlier studies. This again could be explained on the age disparity, as 
rhinitis has a much later onset as compared to asthma. Also, change in 
environment making people more sensitive, more awareness and better 
diagnosis for rhinitis could very well be the contributing factors as well. Like 
in other developed countries, prevalence of atopy related diseases are on the 
rise due to industrialisation and urbanisation (Goh et al., 1996; Wang et al., 
2004). 
Chronic rash has shown a steady increase over the years with 10.5% and 
12.3% in 1994 to 12.5% and 14.9% in 2001 in 6-7 year olds and 12-15year 
olds respectively. In our study of 18-32 year olds, the prevalence of chronic 
rash was found to be 20.98%, a staggering increase considering eczema is a 
childhood disease. Chronic itchy rash on skin flexures has been showing a 
steady increase as well, with 6.1% in 1994 to 9.8% in 2001 for the 6-7 year 
olds and 7% in 1994 to 10.2% in 2001 for the 12-15 year olds and data 
depicting the numbers as 15.7% for 18-32 year olds. Eczema is an early 
childhood disease, often said to trigger the atopic march of asthma and allergic 
rhinitis later on. Like asthma, people are also known to grow out of mild 
childhood eczema. However, the increasing numbers in the 1994 and 2001 
study followed by the high prevalence in a much older age group (Goh et al., 
1996; Wang et al., 2004) suggests a very strong and active environmental 
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component to its manifestation. Another study in Singapore schools was done 
in 2001 using the UK working party's diagnostic criteria which involved a 
questionnaire and a  full body physical examination by one dermatology nurse. 
The prevalence was found to be 22.7% for 7 year olds, 17.9% for 12 year olds 
and 21.5% for 16 year olds which the authors argue is a true representation 
due to the full-body examination (Tay et al., 2002). There has also been a 
remarkable increase in self reporting of eczema, with 3% and 4% in 1994 to 
9% and 6% in 2001. Our data shows this value at 14% for the combined age 
groups (Goh et al., 1996; Wang et al., 2004). This could be explained by the 
higher awareness due to age,  information advancement and  increasing 
prevalence. 
2.4.5 Self-reported prevalence of severity for asthma, rhinitis and 
eczema 
Number of wheezing episodes in the past one year have shown a significant 
decrease in the 6-7 year olds whereas a slight trend of increase has been 
observed in the 12-15 year olds based on the two prior ISAAC studies. On the 
other hand, our data shows an increase in prevalence of 4-12 episodes a year 
(21%)  and a similar prevalence of more than 12 episodes a year (5%). The 
severity of wheezing measured by the number of nights woken up shows a 
reduced trend as compared to the earlier studies, thus showing reduction in 
severity with increase in age. This was also highlighted with the drastic 
decrease in prevalence of speech limitation from a 24% (Goh et al., 1996) and 
18% (Wang et al., 2004) in the 12-15 year olds to 12% in the 18-32 year olds. 
For rhinitis symptoms, earlier studies have shown a significant higher 
prevalence of severity in the 12-15 year olds in the 2001 study as compared to 
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1994 (Goh et al., 1996; Tay et al., 2002). Our data shows a major increase in 
prevalence of the moderate form of rhinitis affecting daily life as compared to 
the previous studies. We further found that one fourth find their symptoms 
troublesome. Also, about 14% of the participants reported the symptoms 
affected their work and leisure activities and around 22% found the symptoms 
causing sleep disturbance. Majority of the cohort has been living with the 
rhinitis conditions for over 10 years (29%) and close to 28% experiencing it in 
the past five years. This number is largely accounted by the section of cohort 
who have been in living in Singapore for less than 10 years. These results 
indirectly show the change in environment affecting a person's allergic status. 
Persistent rash was shown to be reducing with age (6-7 year olds versus 12-15 
year olds) and with time (1994 versus 2001). The trend seems similar within 
the three age groups which reduce with age and are lesser than the earlier two 
studies. The severity of eczema as noted by nights spent awake due to rash 
increased with age and with the time of the study (Goh et al., 1996; Wang et 
al., 2004). However, it seemed to have plateau-ed in the higher age group of 
18-22 and then tapered down in the last age group of 22.01-32. There was a 
higher prevalence of late onset eczema. This could be either due to type of 
collection, as population ascertained in a community setting may have a later 




2.4.6 Association results 
2.4.6.1 Association of demographics to eczema 
Females had a higher prevalence of eczema with OR 1.2, although this may be 
higher or flipped when considering within ethnicities. Higher prevalence in 
females has been reported in other studies as well (Diepgen and Fartasch, 
1992; Goh et al., 1996; Larsen et al., 1996). Interestingly, the older age group 
of 22.01-32 seemed to have a higher prevalence of eczema. This could again 
be due to conclusion put forth by Williams and Strachan that a population 
collection would yield higher number of late onset eczema (Williams and 
Strachan, 1998). Extending this to the recall bias of these participants to the 
more recent past as compared to those who had infantile eczema, the numbers 
would skew towards the older age group. Malays had a higher prevalence with 
odds of 1.97 as compared to Indians. Eczema was found to be more common 
in Chinese and Malays as compared to Indians in Singapore (Tay et al., 2002). 
This was consistent with our results when we controlled for confounding 
demographics (Table 2.5). Also, studies done in Malaysia, a neighbouring 
country with an environment similar to Singapore showed the same increased 
prevalence in Malays and Chinese as compared to Indians (Jaafar and Pettit, 
1993). There was no socio-economic effect observed in the prevalence of 
eczema unlike other allergic diseases. Also, country of birth and years spent in 
Singapore did not show a difference in prevalence. As demographics such as 
gender, age and race showed a significant difference, other variables were 
tested individually and adjusted for the confounding effect of the variables 
(Table 2.5).  
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2.4.6.2 Association of diet and lifestyle to eczema 
Different foodstuffs showed associations with eczema. Group eating cereals 
and rice once or twice a week as compared to daily eaters had a higher 
prevalence of eczema (adjusted OR 1.2 and 1.23 respectively). Eating pulses, 
nuts and potatoes on most days gave an adjusted OR of 1.17, 1.29 and 1.21 
respectively. People who drink yogurt drinks daily had an adjusted OR of 1.2 
indicating higher prevalence. Probiotic drinks have been reviewed to have a 
preventive effect for skin diseases such as eczema, acne, skin hypersensitivity 
(Ozdemir and Erol, 2013; Roudsari et al., 2013). Amongst the list of 
foodstuffs evaluated, fast-food was the most highly associated with adjusted 
OR as 1.37 indicating a high prevalence of eczema in people who consume 
fast food daily as compared to once or twice a week. As the questionnaire did 
not ask questions about diet habits before and after onset of the disease due to 
a possible recall bias, associations of healthy food items as a diet choice 
cannot be concluded.  
Sitting for longer than 5 hours in front of the computer or television or playing 
video games was associated with higher prevalence of eczema at adjusted OR 
of 1.29. Unlike other studies (Pelucchi et al., 2013), pet exposure showed no 
association. Similarly, smoke exposure also showed no association (Morales 
Suarez-Varela et al., 2008). People with drug allergies reported a significant 
higher numbers of eczema as compared to people without drug allergies 
(adjusted OR 1.45) similar to other studies (Baek et al., 2013).  As an 
underlying condition of atopy is a known predisposition factor for developing 
eczema and/or atopic dermatitis (Chew et al., 1999; Goodwin, 2008; Ronchetti 
et al., 2003; Stajminger et al., 2007), we found atopy as measured by allergic 
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sensitisation to common dust mites to be significantly associated with eczema 
with adjusted OR of 1.72. 
2.4.6.3 Association of family background to eczema 
While mother's education showed no association, father's primary education 
group showed a higher prevalence of AD (adjusted OR 1.2). Contrarily, a 
study in Japan showed father's higher education was a risk factor to eczema 
(Miyake et al., 2012). As eczema is a genetic disorder, it was obvious to find 
mother's and father's eczema status strongly associated (Batlles Garrido et al., 
2010). However, father's eczema was most strongly associated (adjusted OR 
3.68) as compared to mother's eczema (adjusted OR 2.64). Mother's eczema 
status followed by rhinitis were associated with eczema. There was no 
association found between maternal asthma and participant's eczema. On the 
other hand, paternal asthma was associated with eczema although least 
strongly compared to father's eczema and allergic rhinitis status. Overall an 
atopic parental background was found to be strongly associated. When 
comparing presence of the disease in both parents, eczema was the only 
disease which showed a strong association with adjusted OR of 3.31. Parental 
allergy defined by the presence of any of the allergic diseases in both the 
parents was also strongly associated. As with other studies, our results also 
show a strong genetic link to AD. 
The genetic link was further corroborated with similar trends in sibling's 
disease status. As compared to siblings with no disease, asthma, rhinitis and 
eczema all showed a positive association. Similarly, family's status as defined 
by both parents and at least one sibling also showed the strong genetic 
association to eczema.  
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2.4.6.4 Association of asthma and rhinitis to eczema 
Asthma and allergic rhinitis were also associated with eczema with rhinitis 
being more strongly associated. Other studies have reported similar 
associations (Batlles Garrido et al., 2010; Garrett et al., 2013; Silverberg and 
Hanifin, 2013). Thus the associations with other atopic diseases suggests a set 
of common underlying candidates for atopy. 
 
2.5 Conclusion 
Comparison between the previously reported epidemiology studies and our 
study showed a steady increase in prevalence of eczema in Singapore. Thus 
highlighting the effect of changing environment. This study also highlights the 
genetic link of eczema, with the strongest association found for paternal 
eczema. Eczema overlaps with asthma and allergic rhinitis in prevalence due 
to the similar underlying atopic cause. But, like any complex disease, eczema 
also has environment as a contributing factor besides genetics. Parameters 
such as gender (female), race (Malay), age, atopy and paternal education seem 
to be shifting the odds towards developing eczema. Other parameters such as 




Chapter 3  
 
Candidate Gene Association Study on 
Atopic Dermatitis in Singapore 
Chinese: Screening and Validation 
 
3.1 Introduction 
Atopic dermatitis is a polygenic multi-factorial disease. The evidence for 
genetics in development of  any disease classically comes from family studies.  
Familial aggregation of AD has been long shown from genetic and 
epidemiological studies since 1982 (Fergusson et al., 1982) to the recent most 
in 2013 (Martin et al., 2013).  Based on previous chapter's results, paternal 
(OR 3.6) and maternal (OR 3.6) eczema have the highest odds of the child 
developing eczema, clearly indicating a strong genetic component. Employing 
ISAAC helped provide a standardised data on prevalence and burden on the 
population. Thus providing the push needed to reveal the underlying factors 
for the variations observed in the disease manifestation (Fok and Wong, 
2009).  
Studies done in Avon county, England show a strong association between 
parental eczema and childhood AD with an odds ratio of 2.72 (95% CI: 2.09 to 
3.53) — both parents affected and odds of 1.7 (95% CI: 1.4 to 2.0) – 1 
affected parent (Wadonda-Kabondo, 2004). Twin studies reporting 
concordance rates of 0.72 - 0.86 in monozygotic and 0.21-0.23 in dizygotic 
twins further confirmed the genetic contribution to the disease (Schultz 
Larsen, 1993; Thomsen et al., 2007).  
49 
 
With the reported literature and our epidemiology suggesting genetic factors to 
be important in the pathogenesis of the disease, then linkage or association 
studies form the next step to determine the genes responsible. Analysis by 
linkage identifies broad genomic regions containing the putative disease 
gene/genes. Linkage analyses relies on co-segregation of genetic loci during 
meiosis in families. By genotyping regularly spaced out markers on the 
genome and studying their segregation in affected pedigrees, relative position 
of the causative regions can be identified (Dawn Teare and Barrett, 2005). In 
linkage analyses, the causative loci is not measured whereas the spaced-out 
markers in the genome are measure with respect to the phenotype. Thus the 
relationship between the marker and the phenotype implies the presence of the 
causative locus in proximity of the marker. The location of the causative locus 
relative to the marker is expressed in terms of recombinant fraction which is a 
non-linear function of the genetic distance between them (Borecki and 
Province, 2008). 
On the other hand, association analyses measures the functional/ causal variant 
either directly or through another marker which is in linkage disequilibrium 
(LD)  with the functional/ causal variant (Boerwinkle et al., 1986). In 
association studies, a higher frequency of a single-nucleotide polymorphism 
(SNP) in the group of individuals affected with a disease can be interpreted as 
that SNP increases the risk of developing the disease. Microsatellite markers, 
insertion/deletions, variable-number tandem repeats (VNTRs), and copy-
number variants (CNVs) can also be used as the marker in association studies 
although SNPs are the most widely tested. Broadly speaking, association 
studies can be classified into four groups, namely, case-control studies in (i) 
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candidate gene study, (ii) genome wide association studies, (iii) family based 
association studies and (iv) quantitative trait locus studies (Lewis and Knight, 
2012).  
Linkage study has many shortcomings, the most important being ascertaining 
a large number of families with several affected generation. If the disease of 
interest has a late-onset with a high mortality, finding families with more than 
one affected generation becomes difficult (Gasser et al., 1998). Generally, 
linkage studies are less helpful for complex traits where different sets of  
multiple genes are important in disease causation in different families. 
Linkage studies are more helpful in identifying loci and genes involved in 
Mendelian diseases. Also, the resolution of linkage analyses is in centi-
Morgans which then further needs deep sequencing and hypothesis for 
identifying the biologically relevant genes within the loci.  
Linkage analysis is effective for relatively low allele frequencies having a 
strong effect size, whereas association studies cover a larger area of relatively 
low-high allele frequencies having a moderate to strong effect size. Thus, 
linkage suits Mendelian  diseases better and association studies suit the 
complex diseases which follow common variant-common disease hypothesis 
(Ardlie et al., 2002). Besides overcoming the shortcomings of linkage study, 
association study also allows for investigating gene-gene and gene-
environment interactions. Hence, due to the varied advantages of association 




 Patterns of LD among SNPs have revealed remarkable distinction between 
the major populations resulting in the human Haplotype Map (HapMap) 
project (http://www.hapmap.org/) (Altshuler et al., 2010). Initially, four 
populations comprising of Han Chinese in Beijing (CHB), Japanese in Tokyo 
(JPT), Yoruba in Ibadan, Nigeria (YRI) and Utah residents with ancestry from 
northern and western Europe (CEU) were studied and their detailed allele 
frequencies and LD pattern made available. The LD pattern has been shown to 
be stable across different individuals  aiding in analysing the genome. The 
resulting correlated alleles within haplotype blocks identifies tag SNPs (t-
SNPs) which form a set of fewer reliable markers within a population for 
analysing their entire genome. This understanding of the structure within the 
human genome has made the genome wide studies on a panel/chip possible. 
This information is also helpful in making one's own customised panel for a 
candidate gene study (Borecki and Province, 2008) and are best suited for 
identifying differences for common diseases (Kruglyak and Nickerson, 2001; 
Nakamura, 2009).   
Based on the justifications and the ease of conducting a candidate gene study 
with a prior well characterised epidemiology population ascertained, I 
conducted a candidate gene screening study on the ethnic Chinese population 
of Singapore. The genes were selected based on the barrier dysfunction 
hypothesis. Genes were identified either through literature or through 
biological plausibility of the gene's product to have a role in maintaining the 
skin's barrier. A comprehensive list of 222 genes was generated. However, due 
to technical and financial limitations only 145 of them could be genotyped. 
Weakly associated, and genes not well replicated in other studies were not 
52 
 
selected in the reduced 145.  The selection for the 145 list was also based on 
the subjective importance given to the gene in pathogenesis of AD. Most of 
the genes worked upon were from chromosome 1 which contains the 
epidermal differentiation complex (Cookson et al., 2001) and filaggrin- the 
most widely associated gene to AD (Barker et al., 2007; Palmer et al., 2006; 
Weidinger et al., 2006) 
Although genome wide association (GWAS) techniques are widely used, we 
did not adopt it, as GWAS needs large sample sizes to conduct a well powered 
study. Ascertaining around 1000 cases would have meant ascertaining 10,000 
samples as AD was found to be prevalent around 10% in our population. Also, 
as my study was hypothesis-driven, unlike a GWAS, we adopted a candidate 
gene approach. We, however, validated the Chinese GWAS in our population 
resulting in a paper as described in Chapter 5. Studies done in our lab 
(Andiappan et al., 2010) have shown than the ethnic Chinese population 
ascertained by us is 95% correlated to the HapMap's CHB population. Hence, 
the CHB database was used as the reference population for identifying SNPs 
in this candidate gene study.  
 
3.2 Materials and methods 
3.2.1 Population ascertainment  
Population was ascertained using a cross-sectional sampling methodology 
from National University of Singapore's (NUS) campus and a paediatric 
allergy clinic from KK Women's and Children's Hospital (KKH). Cases and 
controls for AD were identified and selected based on the questionnaire and 
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skin prick test's (SPT) results. In addition to the samples collected from NUS 
for the epidemiological study, samples were also recruited from an allergy 
clinic at KKH. Approval to conduct this recruitment at KKH was  obtained 
from the Singhealth Centralised Institutional Review Board. Parental or 
guardian consent was  obtained for participants below the age of 21 years and 
$10 vouchers were given as a reimbursement for their participation.  
3.2.2 Disease definition 
For disease classification, participants filled out a standardised and validated 
International Study of Asthma and Allergies in  Childhood (ISAAC) 
questionnaire (Asher et al., 1995) and underwent a skin prick test (SPT). 
Categorisation into the disease bin for either of the three allergic diseases 
required a positive SPT to common allergens found in Singapore. The 
participants were tested for four aeroallergens namely Dermatophagoides 
pteronyssinus, Blomia tropicalis, Elaeis guineensis and  Curvularia lunata. To 
validate the test a positive and negative control, i.e., histamine and saline 
(buffer used for the preparation of the allergen) respectively, were also skin 
pricked. Studies done by the lab previously showed that skin-prick reactivity 
to dust mites especially the two species Blomia tropicalis and 
Dermatophagoides pteronyssinus were highly sensitive and  specific markers 
for allergic sensitization in Singapore (Chew et al., 1999). SPT was considered 
positive when the wheal diameter was ≥ 3mm, whereas no signs of wheal and 
erythema was considered a negative SPT. To ensure the SPT is being carried 
out correctly, a positive reaction to histamine and a negative reaction to saline 
was mandatory before the sample being considered as either a case or a 
control of any of the diseases. Together with the positive and negative 
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controls, a positive reaction to either of the dust mites indicated a positive SPT 
for the participant. Participants with less than 3mm reaction for histamine or, 
erythema or wheal to saline were not considered for defining the cases and 
controls. Participants with  smaller than 3mm reaction to the test allergens 
were considered to have an intermediate SPT result.  
A participant was categorised as a case for AD if he/she answered affirmative 
to "ever had itchy rash" and "rash at skin flexures" in addition to testing 
positive for SPT. Based on UK working party's criteria, flexural involvement 
of rashes had 90% sensitivity and 75% specificity for diagnosing AD 
(Williams et al., 1994a). A subject was categorized as a ‘control’ for AD if 
he/she answered negative to the above questions in addition to a negative 
response to "ever had eczema" with a negative SPT. A participant was 
classified as a case for asthma if they replied positively to "Have you ever had  
asthma?" and had a positive skin prick result. A participant was classified as a 
case for AR if they had at least two recent symptoms from itchy nose, 
sneezing, runny or blocked nose without having flu and a positive SPT result.  
In addition to case and control, 'SPT positive' were samples which had a 
positive reaction to the skin prick test, however did not have disease according 
to the questionnaire. 'Phenotype unknown' were samples who could not be 
classified either as a case or control due to their responses to the questionnaire. 
'SPT inconclusive' were samples which had inconclusive skin prick test results 





For the screening study, 1090 samples comprising of 449 AD cases and 641 
controls were genotyped. The significantly associated genes were then 
validated on a larger population of 732 AD cases, 1085 controls and 650 SPT 
positives & survey negative for AD. 
Samples collected from NUS and KKH were further stratified according to 
severity and chronicity. Severity was defined by the number of nights they 
were kept awake by the itchy rash; mild cases were those that were never 
disturbed at night, moderate were those that were kept awake less than one 
night per week in the last one year and severe were those which cases that 
were kept awake for more than one night per week.  
Chronicity was defined based on the participant's response to two questions- 
namely, presence of rash in the last one year and complete clearance of the 
rash in this past year. Chronic cases were identified as those who replied 'Yes' 
to rash and 'No' to its complete clearing. Similarly, non-chronic cases were 
those who replied 'Yes' to complete clearance when they had a rash in the past 
year, and those who did not have a rash in the past one year . Samples which 
did not provide answers in this format or had missing information to these two 
questions were excluded.  
3.2.4 DNA collection from participants 
Mouth-wash sample was collected from participants recruited from the NUS 
campus. Buccal cells collected in 10ml of 0.9% saline were pelleted by 
centrifuging at 5,000 rpm at 4°C for 15mins. The supernatant was discarded 
and the cells were re-suspended in 500μl of digestion buffer (100mM NaCl,  
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10mM TrisCl at pH8, 25mM EDTA at pH8, 0.5% SDS) and subsequently 
incubated at 37°C overnight in a water bath. Following which steps for 
genomic DNA extraction were performed according to the manual provided  
with AxyPrep Multisource Genomic DNA Miniprep Kit (Axygen). Eluted 
DNA was then quantified in duplicate on the Nanodrop ND-2000 (Thermo 
Scientific). Only samples with DNA absorbance ratios greater than 1.8 at  
260nm/280nm, greater than 1.5 at 260nm/230nm, and with concentration 
higher than 20ng/μl were considered to be of good quality and used for 
downstream genetic analyses. KKH participants provided DNA via a blood 
sample as obtaining a mouth wash samples from the paediatric patients was 
difficult. Hospital's phlebotomist collected a maximum of 2ml blood in 
sodium-EDTA tubes. DNA was extracted according to the manufacturer's 
instructions of the Wizard Genomic DNA Purification Kit (Promega). The 
DNA samples were similarly analyzed and quantified as mentioned above.  
3.2.5 Whole Genome Amplification 
Whole genome amplification was performed on all cases, controls, SPT 
positive samples and the severe AD cases from NSC. We used Illustra 
GenomiPhi HY DNA Amplification Kit (GE Healthcare) to amplify the 
samples. This kit is based on the multiple displacement amplification principle 
(Dean et al., 2002), which allows for the uniform amplification of the whole 
genome producing high yields of DNA amenable to standard genetic analyses 
techniques such as PCR,  sequencing and microarrays (Hosono et al., 2003). 
The amplified DNA was also quantified and analysed as mentioned above. 
Whole-genome amplified DNA samples were used for the candidate gene 
study while the stock DNA samples were used for the methylation study.  
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3.2.6 Selection of SNPs for Genotyping 
Tag SNPs were identified from the genes of interest spanning the gene, 2 kb 
upstream and 1 kb downstream. Tag SNPs were selected using Tagger (de 
Bakker et al., 2005) software integrated with HapMap. Tagging was done 
based on LD. Tag SNPs’ selection criteria was a minimum allele frequency 
(MAF) of 0.05 and LD r
2
 of 0.8 within the CHB population. At the time of 
study, the available full data set release #24 of HapMap was used. The 145 
genes selected were tagged completely by 978 SNPs. 
3.2.7 Genotyping on the Illumina BeadXpress  
Genotyping was outsourced to the DNA Sequencing and Genomics Facility at 
the University of Utah and University of Washington for genotyping on the 
BeadXpress platform using the GoldenGate assay (Illumina)  
3.2.8 Statistical Analyses 
Data and statistical analyses were performed in Microsoft Excel  
(http://office.microsoft.com/en-us/excel/) and online calculators 
(http://www.physics.csbsju.edu/cgi-bin/stats/contingency). Genotyping data 
was analysed using PLINK (http://pngu.mgh.harvard.edu/~purcell/plink/) 
(Purcell et al., 2007) and R (http://www.R-project.org). The model association 
test in PLINK tested for general, multiplicative, additive, dominant and 
recessive models of association (Lewis, 2002). The general model tests the 
differences between genotype counts, the multiplicative model tests for 
differences on allelic counts, both using Fisher's exact test. The additive model 
uses the Cochran Armitage Trend test on allele counts whereas the dominant 
and recessive models tests for dominant and recessive effect of the minor 
allele via Fisher's exact test. Association was tested for all models as no prior 
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assumptions were made. However, only the  general and multiplicative models 
were considered for determining whether an association was present or not. 
SNP call rates and Hardy-Weinberg Equilibrium were used as quality control 
measures. SNPs with a Hardy Weinberg Equilibrium P value of less than 
1x10
-3
 were excluded as they were likely to have genotyping errors. 
Based on the previous chapter on epidemiology of AD in Singapore, 
demographics such as gender, age group and race were shown to be associated 
with the disease and as such may become confounding variables in this genetic 
study. As this study was Chinese race specific, confounding effect of gender 
and age group were tested to check for true association of the SNP to disease. 
This was tested using SPSS (IBM software). 
 
3.3 Results  
3.3.1 Screening study 
3.3.1.1 Population 
Atopic dermatitis is a low prevalent disease as compared to the other allergic 
disease such as asthma and allergic rhinitis. To establish a sizeable cohort for 
the screening study, samples from the campus recruitment along with the 
paediatric allergy clinic of KKH were ascertained resulting in 449 cases and 
641 controls. At the time of the screening study, we had collected 5154 
samples of which 4604 (89.33%) were ethnic Chinese. Based on the DNA 
quality and exclusion criteria, as described in the materials and method, 4550 
samples had good quality DNA (1.17% loss due to bad quality and low yield). 
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The classification of the  population is as shown in the following Venn 
diagram (Fig 3.1)  
 
Figure 3-1: Population ascertained for the screening study. 
Venn diagram showing the overlapping populations of asthma, allergic rhinitis (AR) 
and AD. The AD population (449) was used for the screening study.  
 
By ascertaining 4550 good quality DNA from ethnic Chinese we collected  
742 (16.3%) asthma cases, 1048 (23%) allergic rhinitis cases and a mere 449 
(9.8%) AD cases. Further stratification of the population with respect to AD is 
as shown below. The definition of the classifying terms is as explained in the 
materials and method. 
  Atopic Dermatitis 
 
# % 
      
Cases 449 9.87 
Controls 641 14.09 
SPT positive 2047 44.99 
Phenotype unknown 574 12.62 
SPT Inconclusive 577 12.68 
Indeterminate 129 2.84 
Saline Reaction 133 2.92 
   Total 4550 100.00 
      
Table 3-1: Ethnic Chinese population's stratification for screening study based 




From the population of 4550, 641 (14%) samples fitted our definition of AD 
controls whereas around 45% of the population was skin prick positive to the 
dust mites but responded negatively to the AD questions indicating a very high 
sensitisation of the ethnic Chinese to dust mites. A sizeable proportion of 12% 
replied ambiguously to the AD questions thus rendering them as Phenotype 
unknown. A similar proportion of the population had inconclusive results to 
the SPT i.e., developing a wheal of less than 3 mm for histamine and/or the 
allergens. Close to 3% of the population were classified as AD indeterminate 
as they replied positively to the AD questions, but were SPT negative and a 
similar proportion reacted positively to saline hence were excluded from the 
case and control bins.  
As the study population was ethnic Chinese, we relaxed the age groups for the 
collection. The following table describes the screening population of 449 AD 
cases and 641 controls. 
    Case Control 
    Number (%) Number (%) 
Gender 
Male 195 (43.43) 177 (27.61) 
Female 254 (56.57) 464 (72.39) 
      
Age 
group 
< 18 24 (5.35) 3 (0.47) 
18 - 20 146 (32.52) 255 (39.78) 
20.01 - 22 136 (30.29) 191 (29.80) 
22.01 - 32 138 (30.73) 176 (27.46) 
> 32 5 (1.11) 16 (2.50) 
      Total   449 (100) 641 (100) 
  
 
        
 
Table 3-2: Demographics of the screening population. 





The sex ratio in NUS is skewed towards females which is reflected in our 
recruitment. This has resulted in a higher proportion of females in cases and 
controls with a staggering 72% females accounting for the controls. The age 
band from 18-32 have similar numbers in cases and controls. However, there 
is a higher proportion of cases in less than 18 age group which can be 
explained by the KKH recruitment. The KKH recruitment was conducted in 
the allergy clinic of the paediatric ward resulting in the skew. Senior graduate 
students and staff of NUS accounted for the greater than 32 age group. 
3.3.1.2 Genes and tag SNPs 
A comprehensive list of genes was identified to be tested for association with 
AD. The selection was based on (i) genes reported to be associated with AD, 
(ii) genes coding for proteins associated with AD, (iii) genes associated with 
other barrier dysfunctional diseases, and lastly (iv) selective gene coding 
proteins which were discovered by a senior PhD student in the sweat proteome 
(Manesh 2009, PhD thesis). For the sweat proteome study, sweat-dripping 
method was the method of sample collection, in which sweat which runs over 
skin and drips was used for further proteomic studies using 2DE and 2D-LC-
MS/MS. As skin run-off sweat was collected, it also contained soluble 
proteins of the skin. On careful evaluation of the proteins and their known or 
putative functions 61 genes were identified. This list overlapped with genes/ 
proteins matching the first three criteria for gene selection. Hence, all the 
reported novel associations were obtained from the sweat proteome which had 




A total of 222 genes were identified. Due to limitation of number of SNPs that 
could be probed and financial constraints, we decided to proceed with 
genotyping 145 genes of the 222 genes. The 145 genes were prioritised based 
on the their impact on barrier dysfunction and well documented/ hypothesized 
candidates. Tagging was adopted to reduced the number of SNPs typed. 
Tagging was performed based on r
2
 (LD) of 0.8 and for SNPs with minor 
allele frequency (MAF) of 0.05 and above. The genes were tagged 2 kb 
upstream and 1 kb downstream resulting in 978 tag SNPs representing 145 
genes as shown in Tables 3.3 & 3.4. As evident, chromosome 1 housing the  
epidermal differentiation complex accounts for the maximum number of genes 




 Chr Tags Count 
of gene 
1 117 27  11 113 12 
2 18 3  12 40 10 
3 93 7  14 45 7 
4 8 2  15 22 2 
5 47 5  16 15 2 
6 125 10  17 25 9 
7 4 2  18 120 12 
8 52 10  19 57 10 
9 20 4  20 36 7 
10 17 3  21 4 1 
   
 Total 978 145 
 
Table 3-3: Genes genotyped per chromosome for screening. 
Chromosome (Chr) wise stratification of the 145 genes represented by 978 tag SNPs 






Table 3-4: Genes and tag SNPs genotyped in the screening study. 
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3.3.1.3 Genotyping results 
Analyses for all models of genetic association were tested on the 978 SNPs. 
SNPs associated at a P value of less than 0.05 at either the general or 
multiplicative models were considered significant. A brief summary of the 
chromosome-wise division of the significantly associated tags and genes is as 
shown in table 3.5. Table 3.6 shows only the associated 97 tag SNPs from the 
46 significant genes.  
 
Chr Sig tags Count of sig genes 
1 19 5 
2 4 2 
3 6 3 
5 4 2 
6 16 5 
8 5 2 
9 4 2 
10 1 1 
11 8 4 
12 5 3 
14 4 3 
15 5 2 
16 2 1 
17 1 1 
18 5 4 
19 6 4 
20 2 2 
Total 97 46 
 
Table 3-5: Summary of the significant genes and SNPs per chromosome. 






Table 3-6: Analyses for the significant tag SNPs  at the screening study. 
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 Analyses done at the general, multiplicative models. Gene name, odds ratio(OR) and 
95%confidence interval (CI)of significant SNPs are highlighted in bold. 'a' represents 
the minor allele and 'A' the major allele 
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3.3.2 Validation study 
3.3.2.1 Population 
The 46 genes found associated in the screening study were subjected to a 
another round of genotyping for validation. At the time of the validation study 
7256 samples were ascertained from NUS and KKH cohort. Of them, 6474 
were ethnic Chinese (89.22%) similar to the screening population, suggesting 
a relatively homogenous collection. Based on the quality checks mentioned 
earlier for the DNA yield and quality, 6363 samples yielded working quality 
DNA (1.71% loss). Venn diagram showing the overlap of the three allergic 
disease is shown in Fig 3.2 
 
Figure 3-2: Population ascertained for the validation study. 
Venn diagram showing the overlapping populations of asthma, allergic rhinitis (AR) 
and AD. The AD population (732) was genotyped for the validation study in addition 




By ascertaining 6363 good quality DNA from ethnic Chinese, we collected  
1071 (16.8%) asthma cases, 1648 (25.9%) allergic rhinitis cases and 732 
(11.5%) AD cases. Asthma proportion were similar to the screening 
population, but AR and AD saw a slight increase  
Stratification of the NUS and KKH cohort with respect to AD is as presented 
below in Table 3.7 (definitions are as explained in section 3.2.2). 
  Atopic Dermatitis 
 
# % 
      
Cases 732 11.50 
Controls 1085 17.05 
SPT positive 2773 43.58 
Phenotype unknown 793 12.46 
SPT Inconclusive 685 10.77 
Indeterminate 150 2.36 
Saline Reaction 145 2.28 
   Total 6363 100.00 
      
 
Table 3-7: Ethnic Chinese population's stratification for validation based on 
the AD questionnaire. 
 
The population stratification is very similar to the screening study indicating 
continuous homogenous sample collection. The prevalence of cases and 
controls showed a slight increase as compared to the screening populations 
with the other categories showing less of a difference.   
The validation study was performed on ethnic Chinese samples. In addition to 
732 cases and 1085 controls, 650 skin prick positives (AD survey negative)  
70 
 
were also genotyped. The split up based on demographics of the NUS- KKH 
cohort is shown in Table 3.8. 
  
 
Case Control SPT positive 
    Number (%) Number (%) Number (%) 
Gender 
Male 336 45.90 327 30.14 374 57.54 
Female 396 54.10 758 69.86 276 42.46 
        
Age 
group 
< 18 62 8.47 11 1.01 76 11.69 
18 - 20 232 31.69 417 38.43 187 28.77 
20.01 - 22 237 32.38 344 31.71 254 39.08 
22.01 - 32 192 26.23 281 25.90 125 19.23 
> 32 9 1.23 32 2.95 8 1.23 
      
    
Total 
 
732 100 1085 100 650 100 
 
Table 3-8: Demographics of the validation population. 
AD cases and controls and skin prick test (SPT) positive stratified according to gender 
and age group for the validation study. 
 
The sex ratio was again skewed towards the females with the exception of 
SPT positives. This is due to selection of the 650 highest concentration of SPT 
samples from a total of 2773 samples. The stratification with respect to age is 
similar to the screening study. As there is a wide difference within gender and 
age groups, analyses for the significant SNPs by controlling for gender and 
age group was performed. 
3.3.2.2 Genes and tag SNPs 
Tags from the screening study provided the candidate genes for validation. To 
scrutinize the associations in more detail, the significant genes were re-tagged 
again. Tagging was performed at r
2
 (LD) of 0.8 for SNPs with MAF 0.05 and 
more. According to CaTS power calculator (Skol et al., 2006) with 732 cases 
and 1735 controls (1085 +650), genotyping SNPs with MAF of 0.05 can be 
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found significant at 82% power (1-β error). All genes were re-tagged except 
C11orf30 and only the significant tag SNP was re-genotyped on the larger 
population. This was done due to the SNP number limitation during chip 
design. The genes tagged for the validation study have been listed below in 
table 3.9. 
Chr Gene Sig t- SNPs (Screening) Genotyped for validation 
1 CA6 11 21 
1 CAP1 2 13 
1 CHI3L1 3 12 
1 FLG2 1 2 
1 SPRR2G 2 2 
2 CALM2 3 5 
2 ZAP70 1 11 
3 CD80 2 23 
3 CD86 1 9 
3 CLDN1 3 16 
5 GM2A 1 11 
5 IL7R 3 7 
6 CDSN 1 13 
6 DSP 3 17 
6 OPRM1 3 41 
6 SERPINB6 8 11 
6 SMPDL3A 1 6 
8 ASAH1 2 20 
8 PLEC1 3 7 
9 LCN1 1 2 
9 TXN 3 14 
10 ASAH2 1 6 
11 C11orf30 1 1 
11 CAPN1 1 7 
11 CD44 5 45 
11 CTSD 1 3 
12 KRT5 3 5 
12 KRT6A 1 6 
12 KRT6B 1 4 
14 CMA1 2 7 
14 RNASE7 1 5 
14 SERPINA12 1 20 
15 ANXA2 2 15 
15 CTSH 3 7 
16 PPL 2 13 
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17 GRN 1 8 
18 DSC2 1 8 
18 DSC3 2 27 
18 DSG2 1 10 
18 DSG3 1 12 
19 KLK10 1 9 
19 KLK13 2 6 
19 KLK14 2 6 
19 KLK5 1 11 
20 CTSA 1 5 
20 TGM3 1 20 
Total 46 97 529 
 
Table 3-9: Genes genotyped per chromosome for validation 
Chromosome (Chr) wise stratification of the 46 genes represented by 529 tag SNPs 
that were genotyped in the validation study. 
 
Forty-six genes which were associated at the screening study were re-tagged 
to give 529 SNPs. These SNPs were genotyped on the larger validation 
population. 
3.3.3 Genotyping results 
Analyses for all models of genetic association were tested on the 529 SNPs. 
SNPs associated at a P value of less than 0.05 at either the general or 
multiplicative models were considered significant. After the analysis, 27 genes 
remained associated with AD with the maximum number of tags associated 
from the same gene being CA6 from Chromosome1. The gene-wide tag SNPs 
associated are summarised in Table 3.10. Table 3.11 shows the results on the 
63 SNPs from 27 genes that remained significant when analysed on 732 cases 





Chr Genes Sig tags 
 
1 CA6 8 
 
1 CAP1 2 
 
1 FLG2 1 
 
1 SPRR2G 1 
 
1 CHI3L1 4 
 
2 ZAP70 1 
 
3 CD80 2 
 
3 CLDN1 3 
 
5 GM2A 1 
 
6 OPRM1 3 
 
8 ASAH1 2 
 
9 TXN 3 
 
9 LCN1 1 
 
11 CD44 6 
 
11 CAPN1 3  
11 C11orf30 1  
12 KRT6B 1  
12 KRT5 2  
14 RNASE7 2  
14 SERPINA12 1  
15 CTSH 3  
16 PPL 3  
18 DSC3 1  
18 DSG2 2  
19 KLK10 2  
19 KLK14 3  
20 CTSA 1  
Total 27 63  
    
Table 3-10: Summary of the significant genes and SNPs after validation. 













 Analyses done at the general, multiplicative, additive, dominant (Dom) and recessive 
(Rec) model. Gene name, odds ratio(OR) and 95%confidence interval (CI)of 




In addition, analysis was also performed on 732 cases and 1735 controls (1085 
AD controls + 650 SPT positive), and 732 cases and 650 SPT positives. 
Results for the significant SNPs shown in table 3.12 are below. 
Cases were further subdivided into chronic, non-chronic and mild, moderate 
and severe cases as mentioned in the section 3.2.2. Table 3.13 summarises the 
stratification of cases. 
Analyses were done between chronic versus controls, non-chronic versus 
controls, mild/moderate versus controls and severe versus controls. The results 
did not seem to add more value than the case versus control analyses. To 
further tease out the effect of SNPs on chronicity and severity, analyses were 
performed within the different categories of cases. Table 3.14 shows the 
significant leads of SNPs differentiating chronic cases (n=269) from the non-
chronic ones (n=452). However, when a similar approach was adopted for 
severe cases (n=92) versus mild cases (n=428), the unbalanced analyses did 


























Table 3-12: Analyses for the significant tag SNPs from 






























































Analyses done at the general and multiplicative models. Gene name, odds ratio(OR) 
and 95% confidence interval (CI)of significant SNPs are highlighted in bold. 'a' 









Chronic 269 36.75 
Non-Chronic 452 61.75 
 
Excluded 11 1.50 
    
Severity 
Mild 428 58.47 
Moderate 212 28.96 
Severe 92 12.57 
    
 
Total 732 100 
    
 




Table 3-14: Analyses for the significant tag SNPs as markers for chronicity. 
Analyses done at the general and multiplicative models. 'a' represents the minor 




The wide discrepancy observed in the demographics may form a confounding 
factor in the case-control association analyses. To verify the associations, the 
significant SNPs were re-analysed by controlling for gender and age group. 
The variables used as confounding variables for the genetic analyses are as 
shown in Table 3.16. 
Variable Odds ratio (95% CI) P value 
Gender 
   
Female Ref NA NA 
Male 1.874 (1.516-2.316) <0.001 
Age group 
   
18-20 Ref NA NA 
<18 7.892 (4.042-15.408) <0.001 
20.01-22 0.994 (0.778-1.270) 0.963 
22.01-32 0.989 (0.765-1.279) 0.933 
>32 0.431 (0.20-0.926) 0.031 
 
Table 3-15: Variables for used for adjusting genetic association results. 
 
Due to the manner of subject sampling, age was  expected to have a significant 
association with AD as the samples contributing to the age group of less-than-
18 years came from the paediatric allergic clinic of KK hospital. Also, gender 
with higher prevalence of the disease switched from females (chapter 2 for 
eczema) to males in this cohort of ethnic Chinese AD case-controls. This swap 
is due to the increased number of males in the less-than-18 years group and 
above 32 years of age. Sample ascertainment in the paediatric ward resulted in 
a skew towards males with the odds ratio for males in the group of less than18 
years and above 32 years reached 3.38 (1.52- 7.49), where as the age group of 
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18-32 showed association of males with odds ratio 1.84 (1.50-2.25). To 
control for any confounding effect that may arise due to age and gender, 
associated SNPs were re-tested to yield adjusted odds ratio and 95% 










Odds ratio (OR) and 95% confidence interval (CI) at the aa vs aA a, aa vs AA b and aA 
vs AA c, NS- not significant, Adj- adjusted  
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3.4 Discussion  
The validation study helped identify 27 of the 145 tested genes which are 
associated with AD in the ethnic Chinese population of Singapore. The 27 
genes found significant contain a few known candidates whereas a few are 
novel.  
3.4.1 Genes associated directly with barrier dysfunction 
The gene with the maximum tags being independently associated with AD is 
carbonic anhydrase VI (CA6), a novel candidate identified and validated to be 
associated with AD. Of the 8 signals, minor alleles of 2 SNPs (rs1409147 and 
rs942969) are protective, whereas for the other 6 SNPs, the minor allele has a 
risk-conferring effect. 5 SNPs of the 8 have an allelic effect, whereas 3 SNPs 
(rs2274327, rs2274328 and rs1576766) have a genotypic effect with the 
heterozygous being risk-conferring. CA6 is hypothesized to play a role in 
maintaining the skin pH thereby affecting the processes regulating 
desquamation and barrier integrity. 
Filaggrin 2 (FLG2), a gene found on the epidermal differentiation complex of 
chromosome 1 was validated to be associated in a recessive model with the 
homozygous minor having a risk effect as compared to the heterozygous and 
homozygous major. Different variants in African-American population have 
been associated with persistent AD (Margolis et al., 2013). However, FLG2 
was not found as a marker for chronicity when compared to non-chronic cases 
(Table 3.14) and when comparing chronic cases to controls. It was however, 
associated as a marker for non-chronic versus control with similar odds ratio 
of 2.6 (data not shown). As FLG2 shares similar function and localisation with 
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FLG, it's hypothesized to be involved in a synergistic mechanism with FLG to 
maintain the barrier (Wu et al., 2009). 
 Another gene from the epidermal differentiation complex of 1q21 repeatedly 
associated with AD is a structural protein, small proline rich protein 2G 
(SPRR2G). SPRR2G is from a group of proteins whose regulation in different 
environmental conditions provides adequate barrier function (Cabral et al., 
2001). Through mice studies, it has been shown that oestrogen is an important 
regulator of the members of the SPRR2 family (Hong et al., 2004). In our 
study, when controlling for the effect of gender and age group, we do observe 
a slight increase in odds ratio from 1.581 [case-control association (Table 
3.10)] to 1.695 [association after controlling for gender and age (Table 3.16)] 
for SPRR2G. 
Another gene associated with AD is chitinase 3 like protein, CHI3L1, also 
known as YKL-40. It has been associated with asthma as its circulating levels 
have been correlated with the thickness of the epithelial basement membrane 
(Chupp et al., 2007). Asthma like AD, has an epithelial barrier dysfunctional 
hypothesis of the lungs allowing for increased access of the allergens, 
pathogens and toxins to the airway tissues (Holgate et al., 2009). Based on our 
data, odds of developing AD is 1.57 and 1.61 (unadjusted and adjusted OR) 
times higher with asthma (Table 2.13). CHI3L1 is a known candidate for 
asthma, but a novel candidate for atopic dermatitis showing 4 independent 




Claudin-1 (CLDN1) is associated through 3 tag SNPs. Minor alleles of all 
three SNPs are protective in a dominant manner. Two of these SNPs 
rs3774032 and rs6776378 are also protective with the same strength of OR 
when compared with SPT positives. Claudin-1 is a tight junction protein found 
to be present in higher levels in lesional AD skin as compared to healthy 
controls as compared to non-lesional skin (De Benedetto et al., 2008) 
suggesting a reduction in the baseline levels of CLDN1. As CLDN1 is a tight 
junction protein, a reduction in its levels would result in a less intact skin 
barrier resulting to greater ingress of allergens and pathogens manifesting in 
AD. SNPs from CLDN1 were later shown to be associated with AD in two 
North American populations (De Benedetto et al., 2011). SNPs from CLDN1 
have also be associated with contact sensitisation to nickel and fragrances 
(Ross-Hansen et al., 2013) indicating its vital role in maintaining the skin 
barrier. 
Junction proteins like CLDN1 are important proteins in maintaining cell 
cohesion and thus intactness. Other members such as desmogleins and 
desmocollins forming the desmosomes are also associated with AD. Periplakin 
(PPL), a component of the desmosome, links the desmosome internally to the 
keratins and externally to the cornified envelope. Desmogleins, besides targets 
for the human proteases are also cleaved by Staphylococcal toxins (Hanakawa 
et al., 2002). Staphylococcus infection is present in chronic AD, further 
supporting the observation of DSG2 as a marker for chronicity (Table 3.14). 
Interaction with DSG2 was also found to trigger epithelial to mesenchymal 
transition involving loss of intercellular junctions (Wang et al., 2011). Also, 
DSG2 has been shown to be present in lower levels in AD skin as compared to 
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controls (Saaf et al., 2008). SNPs in DSG2 could either be attributing to the 
reduced expression thereby leaving the epidermis open for pathogens and 
allergens or the SNPs could be making the protein more sensitive to its ligands 
or pathogenic proteases. 
Desmocollin 3 (DSC3) associated with AD is found in basal layers of the 
epidermis. It is shown to counteract the effect of excessive serine proteases by 
upregulating  its own expression (Hachem et al., 2006). Also auto-antibodies 
against DSC3 are found in another barrier dysfunction disease called 
pemphigus vuglaris (Kalantari-Dehaghi et al., 2013). Reduction of DSC3 
expression either through the SNPs of making it a better antigen for auto-
antibodies predisposes an individual to a compromised barrier leading to AD 
phenotype. 
Periplakin is part of the scaffold on which the cornified envelope (barrier 
property) of the outermost epidermal layer develops. Knock-out mice models 
have shown delayed embryonic barrier formation with reduced lipid content 
and mechanical strength (Sevilla et al., 2007). Defective expression of PPL 
has also been observed in AD (Guttman-Yassky et al., 2011). Studies in 
combination with our data strongly associate PPL with AD pathogenesis. 
GalNAc4(Neu5Ac3)Gal4Glc-ceramide ganglioside activator (GM2A) is found 
in the lamellar bodies of the epidermis and is a glycolipid transport protein 
(Raymond et al., 2008). Mice studies have shown the acquisition of epidermal 
barrier by transcription factor Klf and corticosteroids involves the up-
regulation of GM2A by 22 fold amongst other downstream products (Patel et 
al., 2006). These results clearly highlight the plausible role GM2A plays in 
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barrier maintenance and based on our data, its association to AD makes it a 
novel candidate for AD. 
N-acylsphingosine amidohydrolase (acid ceramidase) 1 (ASAH1) is associated 
with AD through 2 SNPs. rs420610 has a strong risk effect in a recessive 
fashion with OR as 1.4 and another SNP rs7460992 confers a marginal risk at 
the allelic level (OR 1.14). The mature protein catalyses the synthesis and 
break-down of ceramides into fatty acids and sphingosine which help in 
retaining moisture and act as antimicrobial agents respectively. In an elegant 
study, Arikawa et al  have shown the association of reduced sphingosine to 
increased Staphylococcus aureus colonisation from involved and uninvolved 
lesions of AD patients versus healthy individuals. They also showed reduced 
acid ceramidase correlating with decreased sphingosine and ceramide 
(Arikawa et al., 2002). Thus suggesting the reduced levels of ASAH1 
contributes to an impaired antimicrobial barrier resulting in AD. 
Calpain1 is associated with AD via 4 tag SNPs 1 of them is a strong marker 
for chronicity. 3 of these SNPs remain significant when regressing for gender 
and age. Calpain1, secreted by the lamellar body (Raymond et al., 2008), is 
involved in the processing of the profilaggrin in differentiating keratinocytes 
(Yamazaki et al., 1997). Filaggrin is the most widely studied and well 
replicated gene associated with AD. If the associated SNPs are involved in a 
change in activity of calpain then it would lead to aberration in the processing 
of filaggrin leading to impaired skin barrier. 
Keratin 5 and 6B are type II cytokeratins co-expressed during differentiation 
of stratified epithelium. Keratins form the key structural component and an 
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aberration in their synthesis or structure may in-turn affect the integrity of 
skin. Previous studies have observed over-expression of KRT6A, 6B in 
chronic AD lesions  highlighting their role in pathogenesis (Jarzab et al., 
2010). On regressing with gender and age group, KRT6B loses significance 
whereas KRT5 remains significant (Table 3.16).  
Ribonuclease, RNase7, is a broad spectrum antimicrobial peptide found on the 
skin. It is a part of the innate immunity by forming an antimicrobial barrier 
thereby preventing pathogens from colonising. RNAse7 is found in lower 
levels of unaffected AD skin as compared to control's (Zanger et al., 2009) 
indicating a broad antimicrobial barrier failure prior to disease manifestation. 
RNase7, like other antimicrobial peptides are inducible upon injury and were 
found to be produced in significantly higher levels in AD as compared to 
controls (Harder et al., 2010) indicating regulation of the skin's antimicrobial 
environment. RNASE7 is associated by 2 independent signals, one having 
protective and the other having a risk-conferring association. 
Proteases and protease inhibitors regulate the activation of different important 
enzymes and help regulate the differentiation and desquamation procedures. 
As members from these two group of proteins regulate homeostasis of the 
barrier, they become obvious choice as candidates for dysregulation. Like in 
other studies, we have found proteases such as kallikreins and cathepsins, and 
protease inhibitor from the serine protease inhibitor (SERPIN) family 
associated with AD.  
The usual serine protease candidates are KLK5 and KLK7, however, we have 
detected KLK10 and KLK14 to be associated with AD in our population. 
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KLK10 and KLK14 have been shown to be up-regulated in SC of AD patients 
(Komatsu et al., 2007). However, it remains to be ascertained if the levels are 
associated with the significant genotypes in our population. KLK14 has been 
shown to activate the pro-protein forms of KLK5, KLK1 and KLK11 (Emami 
and Diamandis, 2008) and to cleave desmogleins (junction proteins) at a 
greater rate than KLK5 (Brattsand et al., 2005). KLK14 is also correlated with 
increased trans-epidermal water loss and reduced hydration (Stefansson et al., 
2008), highlighting it's critical role in maintaining the integrity of the 
permeability barrier. All 3 SNPs from KLK14 have a protective role whereas 
the 2 SNPs from KLK10 have a risk-conferring role with one of them having 
an OR of 1.5. However, after controlling for the effects of demographics, 1 
SNP from KLK14 and both SNPs from KLK10 remain significant.  
We tested all members of the cathepsin family of cysteine protease and found 
cathepsin A (CTSA) and cathepsin H (CTSH) to be associated in our 
population. Cathepsin S over-expressing transgenic mice induced scratching 
behaviour via proteinase-activated receptor-2 (PAR-2) showing chronic AD 
symptoms (Kim et al., 2012). Low levels of cathepsin E were observed in AD 
subjects and mice models lacking this protease spontaneously developed AD 
lesions suggesting its role in pathogenesis (Tsukuba et al., 2003). Reduction in 
cathepsin G positive cells is also shown to be associated with clinical 
improvements (Breuckmann et al., 2002) linking reduced protease to skin 
improvement. There is no direct reported association of CTSA and CTSH to 
AD, but based on the links to other members of the same family, these 2 novel 
validated candidates provide a direction for future research.  
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One SNP from SERPINA12 was found associated in case versus control 
analysis however, 4 with chronicity. As mentioned above the importance of 
serine protease in regulating homeostasis of the epidermis, their regulation by 
inhibitors also becomes crucial for the same. Mice studies have shown the 
acquisition of epidermal barrier by transcription factor Klf and corticosteroids 
involves the upregulation of SERPINA12 by more than 10 fold amongst other 
downstream products (Patel et al., 2006) highlighting its role in barrier 
acquisition. Dyregulation of SERPINA12 is also associated with psoriasis, 
another barrirer dysfunction disease (Gudjonsson et al., 2010). 
3.4.2 Genes associated indirectly with barrier dysfunction 
Heterogeneity of ZAP70, zeta-chain of T-cell antigen receptor associated 
protein kinase deficiency has been reported to present atopic dermatitis in 
some patients (Turul et al., 2009). Others have suggested deficiency of ZAP70  
predisposes one to exaggerated inflammation and autoimmunity (Poliani et al., 
2013; Roifman et al., 2010). Besides, barrier dysfunction and atopy, 
autoimmunity is also a suggested mechanism of pathogenesis. Altered T- cell 
receptor signalling is also a known cause of allergic diseases (Datta and 
Milner, 2011). This could explain the loss of significance when testing AD 
cases against SPT positives (Table 3.12), besides the lack of power to detect 
association with such low numbers. From Tables 3.14 ZAP70 appears to be a 
marker for non-chronic AD. 
Cluster of differentiation/designation (CD) 80 is strongly associated with AD 
in a recessive manner with OR ranging from 2.3-2.5 for the 2 SNPs. The OR 
slightly increases when tested against SPT (Table 3.12) for rs6778945 and a 
third SNP gets highlighted to be significant in a protective manner indicating 
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independent and opposing effects of the minor alleles. CD80 binds to CD28/ 
CTLA4 activating Th2 subset of T-helper cells mediating allergic 
inflammation (Lanier et al., 1995). CD80, CD86 mapped to 3q21 has been 
reported as a major susceptibility locus for AD and allergic sensitisation 
through genome wide linkage study (Lee et al., 2000). CD80 has been found 
to be associated with AD at meta-analysis (Cao et al., 2009). Others have 
shown that Langerhans cells and inflammatory dendritic epidermal cells show 
increased expression of CD80 and CD86 in AD skin indicating its role in 
pathogenesis of AD (Schuller et al., 2001).  
Opioid receptor, μ1 (OPRM1) is expressed on skin epidermal keratinocytes 
and melanocytes. They are responsible for regulating pain and itch sensations 
particularly in chronic dermatitis. They are also involved in skin 
differentiation , wound healing and scar formation. Signal transduced by μ 
opioid receptor is known to stimulate itch (Bigliardi et al., 2009). Enhanced 
itch sensation further leads to the scratch-itch cycle promoting barrier 
dysfunction and thus AD. OPRM1 is associated through 3 tag SNPs in a 
recessive manner, 2 of the SNPs having a protective role whereas one has an 
OR of 2.2 (Table 3.10). When analysed in chronic vs non chronic cases 4 
SNPs turn out significant with 3 being markers for non-chronic AD and 1 for 
chronic AD (Table 3.14) . 
Thioredoxin (TXN) is associated with AD through 3 tag SNPs 2 of them 
protective in a dominant manner and the third SNP is risk-conferring in a 
recessive fashion. The protective association gets stronger when controlling 
for gender and age however, the risk-conferring SNP loses significance. 
Thioredoxin is a cross reactive allergen from fungus known to contribute to 
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asthma and AD. Studies have shown auto and cross reactivity to the human 
form by IgE from patients (Glaser et al., 2008). Thioredoxin may thus be 
involved in the pathogenesis of AD through atopy and auto-allergy. 
Lipocalin1 (LCN1) is associated through 1 SNP with OR 1.3 which remains 
significant after controlling for gender and age. Lipocalins are proteins that 
bind to various hydrophobic ligands and transport them extracellularly. They 
are inducible under stress and infection. Most of the mammalian allergens 
belong to the family of lipocalins (Chapman and Wood, 2001). The similarity 
of human and allergen source lipocalin may be involved in the manifestation 
of atopy (Virtanen et al., 1999), thus leading to AD. Also, LCN2, another 
member of the same family has been shown to be downregulated  in lesional 
AD skin along with other innate defense proteins (Guttman-Yassky et al., 
2008). 
CD44 was associated with AD through 6 tag SNPs and all remained 
significant after controlling for demographics (Tables 3.10 and 3.16). One of 
the SNPs was found to be a marker for chronicity (Table 3.14).  CD44 is 
implicated in a variety of functions ranging from cell-adhesion, migration, 
lymphocyte activation and homing to tumor metastasis. Diversity in function 
for CD44 is attributed to its complex alternative splicing. Ex vivo experiments 
on eosinophils from AD patients showed a significant higher expression of 
CD44 as compared to healthy controls' (Ogawa et al., 2003). Knock-out mice 
experiments have shown the importance of CD44 in committing to leucocyte 
extravasation at the site of allergen challenge (Gonda et al., 2005). Also, 
disruption of the epidermal permeability barrier increases CD44 expression 
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(Man et al., 2009). Thus, CD44 is associated with AD via the atopy and 
barrier dysfunction hypothesis.  
3.4.3 Miscellaneous association 
CAP1 is a serendipitous association as the gene of earlier interest was PRSS8 
which is also known as CAP1 from chromosome 16, which has been 
associated with barrier dysfunction (Frateschi et al., 2011; Leyvraz et al., 
2005). However, while tagging, we tagged another gene adenylate cyclase-
associated protein 1 abbreviated as CAP1 from chromosome 1 in addition to 
PRSS8. PRSS8 wasn't significant in the screening but CAP1 was and thus was 
put through validation and it remained significant with 2 tags being associated 
at the genotypic level. Thus, this is also a novel association to AD.  
C11orf30 was tagged at 5% MAF at the screening round yielding 11 tags 
representing the gene (2 kb upstream and 1 kb downstream) out of which 1 tag 
was significant. Due to limitation in the number of SNPs on the chip, instead 
of re-genotyping the 11 tags on the larger validation population, only the 
significant SNP was genotyped and it was validated. A SNP 38kb downstream 
of C11orf30 was reported through a GWAS for AD (Esparza-Gordillo et al., 
2009) and for Crohn's disease which is another barrier dysfunction disease 
(Barrett et al., 2008). This gene codes for a nuclear protein which inactivates 
BRCA2 and is known to localise at DNA repair sites. It is found to be up-
regulated in epithelial tissue cancers of breast and ovaries (Hughes-Davies et 




The study yielded 27 candidate genes associated with AD six were novel. 
Most of the candidates can be attributed to AD through barrier dysfunction 
hypothesis. The ones not directly associated with maintaining the barrier such 
as candidates of atopy, sensitivity to excessive itch, auto-allergy can also 
indirectly lead to a compromised barrier.  
This study has found associations to genes which were hypothesized based on 
their function but never actually shown genetically. The vast types of genes 
associated such as proteases, tight junction proteins, antimicrobial peptides, 
CD markers and genes overlapping with asthma shows the spectrum of 





Chapter 4  
 
Functional characterisation of CA6 
 
4.1 Introduction 
The results from the previous chapter point towards a multiple set of genes 
associated with AD. The genes implicated are either a direct risk of barrier 
dysfunction or an indirect risk leading to barrier dysfunction. Among the set of 
27 genes found associated, carbonic anhydrase VI (CA6) has the maximum 
number of tags associated with AD and is a novel candidate. Thus, CA6 was 
decided to be taken forward to evaluate functionally. Although the remaining 
26 genes are also significant and work on them is in progress, CA6 being a 
novel candidate and having the maximum number of associated SNPs was 
chosen for further characterisation. 
4.1.1 Exome and alternative splicing 
Excess of proteome when compared to the genome explains alternative 
splicing as a mechanism for expanding information from a limited source 
(Nilsen and Graveley, 2010). In recent years, alternative splicing has been 
estimated to be present in over 95% of the genes containing multiple exons 
(Blencowe, 2006). As such, differential splicing patterns serve as a key area 
for gene expression (Zhou et al., 2013). CA6 like many genes is known to 
undergo alternative splicing. To check whether alternative splicing occurring 
in CA6 is associated with any of the significant SNPs, exon array study was 
conducted in an ex vivo manner. Differential splicing would provide 
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information on the exons being spliced out and whether selective patterns of 
splicing are predisposed by the associated SNPs.  
4.1.2 Epigenetic methylation 
Epigenetic regulation by methylation has been shown to have a regulatory 
effect (Lorincz et al., 2004) to processes such as gene expression (Phillips, 
2008) and splicing (Maunakea et al., 2013). To better understand our gene 
expression and alternative splicing results, we undertook a methylation study 
and analysed the patterns with the associated SNPs. As the downstream of 
genetic and epigenetic regulations finally affects the protein levels, stratum 
corneum collected from the participants (Dreher et al., 2005) was tested for 
CA6 levels via immunoblotting. 
4.1.3 pH 
The gene of interest - CA6, which although doesn't have a known function on 
the skin, is implicated to regulate pH (Khalifah, 1971a) primarily in the 
alimentary canal (Parkkila et al., 1994), and in milk (Karhumaa et al., 2001). 
The outer layers of stratum corneum is long known to have an acidic pH 
(Hetjss, 1892). Studies have shown a biphasic curve wherein the pH 
approaches neutrality in the lower layers of SC  and then reaching a more 
acidic pH at the interface of the SC and stratum granulosum to then shift to 
neutrality again (Fluhr and Elias, 2002). Increased pH, considered a cause 
(Cork et al., 2009) and an effect of barrier dysfunction (Ohman and Vahlquist, 
1994), is an important physiological characteristic worth noting in AD. As a 
result, we measured skin pH on the re-called population of cases and controls 
and their readings were analysed in association to the significant SNPs. 
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4.1.4 Trans-epidermal water loss 
Another hallmark of a dysfunctional barrier and AD is increased trans-
cutaneous water loss associated with dry skin (Fluhr et al., 2006). As 
explained in Chapter 1, skin with more physical gaps due to inherent 
aberrations  or external sources will provide route for evaporative water loss. 
To measure this marker of a compromised barrier, trans-epidermal water loss 
(TEWL) was measured on re-called subjects and its association to the 
significant SNPs was tested.  
4.1.5 In vitro characterisation 
The different associations pointed towards functionality of the SNPs which 
requires further research. However, it is unlikely for a single SNP to have a 
strong enough effect to cause a disease. To cause a strong effect, the SNP in 
combination with other SNPs around it gathers the biological function to 
execute or modify a function. A combination of SNPs present on a 
chromosome which are passed down together are haplotypes. Thus, haplotype 
becomes the unit of functional inheritance within a gene. To evaluate the 
effect of the associated variants to gene function and ultimately to disease 
manifestation/ progression, we first found the haplotypes within our working 
population. As the significant SNP was a tag SNP, all SNPs in LD with the tag 
SNP were also considered significant and evaluated for a causal role. 
Haplotypes spanning significant SNPs were identified either through 
resequencing and/or by using HapMap data. Haplotypes prevalent at a 
frequency of 5% or higher in the population were considered for further 




4.2 Materials and method 
4.2.1 Differential splicing and gene expression 
To evaluate the differential spliced variants present ex vivo, samples were 
subjected to Affymetrix's Human Exon ST1.0 microarray. This array measures 
each exon by a probe giving higher probe density and better coverage than 
other conventional arrays available. Besides measuring differential exon levels 
resulting from alternative splicing, the chip also allows for measuring 
differential gene expression (Okoniewski et al., 2007). RNA extracted was 
sent to Origen Laboratory where they performed the quality checks and ran the 
microarrays and raw data was provided to the lab. 
4.2.2 Regulation by differentially methylated regions 
To further evaluate the next layer of regulation involved, we undertook an 
epigenetic study to identify genome wide differentially methylated regions. 
Stock genomic DNA was subjected to Infinium HumanMethylation450 
BeadChip (Illumina) and results were analysed for differences between 
methylation sites between cases and controls and between genotypes 
irrespective of disease status. 
4.2.3 Stratum corneum collection and protein quantification 
The SC was collected from participants at the inner flexure of the elbows by 
tape stripping. Tape discs of 22mm diameter (CuDerm) were stamped at and 
around the folds within a defined area. The protein was extracted by freeze-
thawing and sonication and later subjected to immunoblotting for measuring 
relative levels of CA6. Analyses was done to check for differences between 
case-control and between genotypes. 
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4.2.4 TEWL and pH measurements 
Trans-epidermal water loss and skin pH were measured on a recalled 
population. TEWL was measured with the help of Tewameter TM 300 MDD 
(Courage + Khazaka electronic GmbH) and pH was measured using the same 
company's pH probe 905. The recalled participants' skin conditions were 
equilibrated to the measuring environment's condition by letting them sit in the 
same room for 30-45 min before starting the measurements. TEWL and pH 
readings from both arms were taken. The participants were then tape stripped 
on both arms in a defined area. After tape stripping, TEWL and pH readings 
were taken again from both arms. The recalled population was called for two 
visits and the same procedure was conducted again on the 2nd visit. 
Differences between the genotypes of the significant tag SNPs were analysed 
against different TEWL and pH parameters. 
4.2.5 Statistical analyses. 
Excel (Microsoft) and SPSS (IBM) were used for the different analyses. For 
all the experiments, due to the limited sample size, non-parametric analyses 
such as Mann-Whitney-Wilcoxon and Kruskal Wallis methods were applied. 
As the epigenetic methylation study was a whole genome study, analysis was 
done with the parametric equivalent tests of analysis of variance (ANOVA). P 
value of less than 0.05 was considered significant. 
4.2.6 Functional predictions 
The significant SNPs and the SNPs in LD with the tag SNPs were evaluated 
for their putative functions through different databases. Depending on the 
region where the haplotypes spanned, functional predictions for various 
functions were done. Significant regions within the 5' untranslated region (5' 
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UTR) or upstream of the gene or in the first intron (Coulon et al., 2010) were 
evaluated for promoter activities. Significant regions within the intron-exon 
boundaries were evaluated for their putative effect on splicing. Overall, 
functions of the SNPs were evaluated in SNPinfo 
(http://snpinfo.niehs.nih.gov/snpinfo/snpfunc/), F-SNP 
(http://compbio.cs.queensu.ca/F-SNP/). SNPs that lay in the upstream or first 
intron were evaluated for promoter activity through TFSearch 
(http://www.cbrc.jp/research/db/TFSEARCH.html) and ConSite 
(http:/www.phylofoot.org/consite). SNPs within the 300 bases of the intron-
exon boundaries were predicted for their putative splicing functions through 
Human Splicing Finder (http://www.umd.be/HSF/). SNPs in 3'UTR were 
evaluated for miRNA based regulation through a miRNA database 
(http://www.mirbase.org/). Overall information on domains coded by different 
exons was sourced from Uniprot database (http://www.uniprot.org/). 
4.2.7 Re-sequencing 
2 kb upstream area of the gene was re-sequenced to find the haplotypes 
prevalent in the working population. Re-sequencing was performed by 
Sanger's dideoxy-nucleotide method (Sanger et al., 1977). 40 samples 
randomly chosen from the cohort of Singapore Chinese samples were selected 
for sequencing to be able to identify SNPs with a frequency of 1.25% or more. 
Briefly, the area of interest spanning 2 kb upstream and 1kb into the start of 
the gene was amplified using a high fidelity polymerase such as Kapa HiFi 
(Kapa Biosystems) or Phusion (Thermo Scientific). This product was then re-
sequenced using BigDye terminator kit (Applied Biosystems) spanning areas 
around significantly associated SNPs and around the intron-exon boundary. 
103 
 
SNPs confirmed by re-sequencing in forward and reverse direction were then 
identified by comparing to dbSNP 
(http://www.ncbi.nlm.nih.gov/projects/SNP/) to check for known and novel 
SNPs found through resequencing. 
4.2.8 LD and haplotypes 
SNPs found through resequencing, HapMap and Singapore Genome Variation 
Project (SGVP) (http://www.statgen.nus.edu.sg/~SGVP/) were tested for LD 
and haplotypes were obtained using Haploview 
(http://www.broadinstitute.org/scientificcommunity/science/programs/medical
-and-population-genetics/haploview/haploview). Haplotypes with a MAF of 
less than 0.05 were excluded. Constructs for the haplotypes were either made 
in the lab through cloning procedures or purchased from Genscript. 
4.2.9 Cloning 
Clones for the promoter assay were prepared using routine cloning procedures. 
Primers containing restriction enzyme (RE) sites were used to amplify the 
different haplotypes. PCR product and the vector pGL4.10 (Promega) were 
digested with the set of XhoI-EcoRV and NheI-HindIII (New England 
Biolabs) REs and then ligated with T4 ligase. The ligated product was 
transformed in TOP10 cells (Invitrogen) and successfully transformed 
colonies were picked for plasmid extraction. Wizard Plus SV Miniprep DNA 
Purification System (Promega) was used to extract the plasmid DNA and 
checked for the correct sequence through sequencing. Colonies with correct 
sequence were then scaled up to grow in 200ml Luria Bertani broth and 
plasmid was extracted using PureLink HiPure Plasmid Filter Purification Kits 
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(Invitrogen). The sequence was again verified, quantified and used for 
downstream cell culture work. 
4.2.10 Cell lines and transient transfection 
Cell lines of mammalian origin were used to avoid the genetic variability 
associated with primary cells. Cell lines such as HaCat and HEK293T were 
used for the different in vitro assays. HaCat cells are normal keratinocytes 
which underwent spontaneous immortalisation to result in a nontumorigenic 
cell line (Boukamp et al., 1988). HaCat were grown and maintained in  
Dulbecco's Modified Eagle Medium (DMEM, Sigma-Aldrich) supplemented 
with 10% foetal bovine serum (FBS, GIBCO). Another cell line namely 
HEK293T were also used for the in vitro experiments. Although not originated 
from skin, HEK293T are well known for their ease of transfectability and 
were used to counter cell-line specific bias. HEK293T were grown in RPMI-
1640 (Sigma-Aldrich) supplemented with 10% FBS. All cell lines were grown 
in a greater than 80% humidity, 5% CO2 environment at 37°C. 
Cells were grown in 24 well plates until they reached more than 80% 
confluency. The plasmids containing haplotypes of interest were then 
transiently transfected using Lipofectamine 2000 (Invitrogen) according to 
manufacturer's instruction. The optimised ratio of DNA: Lipofectamine was 
1:3 for the splicing experiment and 1:5 for the promoter experiment. Cells 
were harvested at 24 and/or 48hrs after transfection. 
4.2.11 In vitro promoter activity assay 
Promega's Dual Luciferase reporter system was used to measure promoter 
activity. The pGL4.10 vector contains a promoter-less fire-fly luciferase. The 
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test haplotypes were inserted in the multiple cloning site of this promoter 
which is upstream of the gene coding fire-fly luciferase enzyme. The 
recombinant pGL4.10 was co-transfected with pGL4.74 which has a HSV-TK 
promoter in front of renilla luciferase. The ratio of firefly luciferase to renilla 
luciferase used was 400:1. This was transfected in HaCat and HEK with 
Lipofectamine at a ratio of 1:5. Cells were harvested at 24hr for the upstream 
contruct and at 48 hrs for the intron 1 construct. The cells were lysed with the 
lysis buffer provided in kit and subsequent steps followed as per 
manufacturer's instructions. Luminescence was read in a Veritas Microplate 
Luminometer (Turner Biosystems). Luminescence was normalised by taking 
the ratio of firefly's luminescence over renilla  luminescence readings and 
checked for differences between haplotypes. The experiment was conducted in 
triplicates and repeated a minimum of three times. Difference were checked 
with student's t-test. 
4.2.12 In vitro differential splicing assay 
The mini-gene assay was used to check for the differences in splicing patterns 
of the 2 constructs (Gaildrat et al., 2010). As the constructs involved joining 
different exons with their 200-300 bases flanking introns, to be compressed 
into a mini-gene, the constructs were ordered rather than made in the lab. The 
constructs were ordered in the mammalian expression vector pcDNA3.1. Post 
24 hrs of transfection, the cells were harvested and RNA extracted using 
E.Z.N.A.Total RNA kit (Omega). Equal amounts of RNA from the different 
haplotypes (400ng) was converted to cDNA using iScript cDNA Synthesis kit 
(Bio-Rad). To selectively amplify the regions of interest, primers in extreme 
exons were used to PCR the cDNA. Fluorescent dye FAM was run along in 
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the PCR to be incorporated by a low-fidelity Taq polymerase (Vivantis). The 
presence and relative abundance of the splice variants were analysed 




CA6 is a large 29.2 kb gene on chromosome 1 and is made up of (at 
maximum) 9 exons. CA6 had 8 tags associated with AD after the validation 
study. Following table 4.1 is a recap of the association of the significant SNPs 
from CA6. The risk allele and genotypes has been identified by the odds ratio 
and presented here in terms of A and B for ease of understanding. 
 
Table 4-1: Significant associations of CA6 
CA6 being a large gene has multiple spliced variants. Aceview from NCBI 




Figure 4-1: Different spliced forms of CA6 
Different alternatively spliced variants of CA6 as reported in AceView (NCBI) 
4.3.1 Exome array 
To evaluate the presence and effect of the associated SNPs, we undertook a 
whole genome exome analysis on 20 samples as described in section 4.2.1. 
Data shown here is for the gene of interest- CA6 alone. There were 16 probes 
in the Affymetrix Human exon array ST1.0 array to probe for the different 
exons of CA6. For obtaining the exon probe data, the exon scores were 
normalised with respect to the complete gene expression scores. Genotypes of 
the 8 significant tags were analysed with respect to the gene expression and 
probe specific data. The table below (Table 4.2) compiles only the significant 
associations (P values < 0.05) found between the 8 SNPs' genotypes with 




Table 4-2: Exon probes associated with the significant SNPs. 
The table shows the region in the gene where the probe sets map to. Of the 8 
SNPs analysed against the 16 probes, 3 SNPs showed association in 4 of the 
probe regions, and 2 SNPs showed association with gene expression. 
Figure 4-2: Gene expression data for associated SNPs. 
Figure 4.2 shows the gene expression data with respect to the 2 significant 
genotypes. For rs2274328, gene expression was significantly different 
between the AB and BB genotypes. As shown in Table 4.1, AB genotype is 
the risk-conferring genotype indicating that the it leads to enhanced gene 
expression of CA6. 
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For rs11576766, AB genotype showed the significantly higher gene 
expression as compared to AA and AB. As shown in Table 4.1, AB genotype 
is the risk-conferring genotype indicating that the it also leads to enhanced 
gene expression of CA6, similar to rs2274328. 
This suggests that overall cases have a higher expression of the CA6 gene 
 
Figure 4-3: Exon-probe expression data for associated SNPs. 
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Exon probe expression for: p_2319138 vs rs1409147 (A), p_2319141 (B1) and 
p_2319155 (B2) vs rs2274328, and p_2319138 (C1), p_2319155 (C2) and p_2319156 
(C3) vs rs11576766. 
 
Figure 4.3 shows the exon probe expression data with respect to the significant 
SNPs as indicated in table 4.2. SNP rs1409147 found upstream of the gene 
was associated with the probe probing for exon 1 of the gene, suggesting the 
SNP affects the expression of exon 1. The risk-conferring allele as described 
in table 4.1 is B. The BB genotype is shown to have a lower expression of 
exon 1 as compared to the heterozygous state (Figure 4.3A). 
Figure 4.3B shows the difference in exon expression data when compared with 
rs2274328. AB genotype which confers risk shows increased levels of exon 
expression for exon 1 (Figure 4.3B1) and exon 9 (Figure 4.3B2). This is in the 
same trend as the overall gene expression by the same SNP. 
Figure 4.3C shows the exon expression data for rs11576766 with respect to 3 
different probes. The 3 probes are present upstream of the gene, in exon 9 and 
in the 3'UTR after exon 9. The risk-conferring genotype AB, shows an 
increased trend for the regions following the same trend as gene expression in 
Figure 4.3. 
To understand the mechanism by which the above SNPs affect gene 
expression and alternative splicing, we undertook a methylation study. 
4.3.2 Methylation study 
To evaluate the regulatory effect of the associated SNPs, a genome-wide 
epigenetic study to find differentially methylated regions was undertaken on 
19 AD cases and 20 controls using Illumina's technology as described in 
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section 4.2.2. Data analysed is only for the 11 probes that spanned CA6 and 
regions around it. Table 4.3 below contains the compiled results for only the 
significant probes (P value <0 .05) with respect to the genotypes. As the 
dataset contained a sizeable number of cases and controls, analysis was also 
carried out to check for differences in the methylation with respect to disease. 
 
Table 4-3: Methylation probes associated with the significant SNPs. 
The top row of the table gives information of the position of the probes. There 
was a difference in the methylation pattern of cg24052039 between cases and 
controls. And this probe maps to the upstream area of the gene, suggesting 





Figure 4-4: Methylation profile of associated SNPs and disease status. 
Figure 4.4A shows that cases have a slightly higher methylation profile at the 
given upstream marker. As methylation in the upstream region of the genes 
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results in gene-silencing, these results indicate that cases having down-
regulation leading to low expression of CA6. 
The intron 1 SNP rs942969 showed decreased methylation in the risk-
conferring genotype BB. The decreased methylation found after E1 could 
either result in increased expression of CA6, which is in line with the exome 
array or could affect alternative splicing (Figure 4.4B).  
The SNP in rs2274327 shows increased methylation in AB risk-genotype 
(Figure 4.4C). The location of this probe is between E6 and E7 indicating a 
role in splicing.  Similarly, rs2274328 showed increased methylation in AB 
(risk-conferring genotype) and highest in BB (risk-conferring allele) (Figure 
4.4D). The probe lies between E6 and E7 and is known to affect the area 
between the introns (Illumina information). 
SNP rs3765965 shows a stark difference in the methylation patterns between 
AA and AB. The samples put through the methylation did not have a BB for 
rs3765965 as B is the minor allele. From the graph (Figure 4.4E), it can be 
interpreted that BB might have a reduced expression as the presence of just 
one B in the heterozygous state caused a large difference. The probe 
associated with this SNP lies between E5 and E6, again suggestive of 
regulating alternative splicing. 
For SNP rs11576766, AB genotype confers risk over AA and is protective 
over BB (Table 4.1). The table shows a significant difference between AA and 
AB. From the figure (Figure 4.4F), AB has a higher methylation than AA, 




Figure 4.4G shows the risk-conferring genotype AB of rs11576766 to have a 
higher methylation upstream of the gene, suggestive of a down-regulation of 
CA6 expression.  
SNP rs17032921 shows higher methylation in BB genotype. The risk 
genotype AA is absent due to the limited number of samples assayed. The 
graph (Figure 4.4H) can be extrapolated to suggest that the risk genotype (AA) 
has a much lower level of methylation, as with the presence of the allele A in 
the heterozygous state is enough to show a statistical difference. Thus, a lower 
methylation state between E5 and E6 associated with rs17032921 seems to 
affect splicing in cases. 
Our experiments strongly suggest that splicing and gene expression is affected 
by the associated SNPs. The downstream effect of these processes would 
affect the translated CA6 protein on the skin.  
4.3.3 Protein levels from stratum corneum 
Stratum corneum samples were collected from 25 cases and 59 controls. CA6 
was measured via immunoblotting. There was no significant difference 
between cases and controls (Figure 4.5). This could be explained by the 





Figure 4-5: CA6 protein levels between cases and controls. 
The protein levels were also checked against the genotypes for the associated 
SNPs. No association was observed. The effect of alleles were also compared 
to the levels of CA6 and upstream SNP rs1409147 showed mild association (p 
value 0.046) as shown in Figure 4.6. SNP rs942969 which had a similar effect 
on the disease status (Table 4.1) showed a similar trend although was not 
found to be significant. 
 
Figure 4-6: CA6 protein levels for rs1409147 and rs942969. 
The graph above (Figure 4.6) shows that associated SNPs found upstream 
(rs1409147) and in intron1 (rs942969) may have an effect on the levels of the 
protein expressed.  
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4.3.4 pH and TEWL readings 
To evaluate the physical and biological effect of these SNPs, a sub-population 
was re-called and TEWL and pH readings were measured on 15 cases and 41 
controls. The TEWL readings were measured before and after tape stripping. 
Tape stripping simulates barrier dysfunction and thus we recorded any 
changes in skin parameters between cases and controls  Only the significantly 
associated SNPs with TEWL and pH readings are described in the Table 4.4. 
 
Table 4-4: pH and TEWL associated with significant SNPs. 
 
Table 4.4 shows only the SNPs associated at the different levels of 





Figure 4-7: pH readings for associated SNPs. 
pH readings were found to be different for 2 of the 8 SNPs. rs11576766 
showed a difference between AB and AA. AB genotype which is risk-
conferring showed an increased pH post-tape stripping. rs7545200 was found 
to have a higher pH reading in AB as compared to BB before tape stripping 
and in general. The risk allele A which is present in the heterozygous state 
showed a consistent high pH reading in both scenarios and in the similar 




Figure 4-8: TEWL readings for associated SNPs. 
TEWL reading was found to be lower in AB as compared to BB. The risk-
conferring genotype AB showed lower trans-epidermal water loss in general 
and post-tape stripping. 
4.3.5 In vitro experiments 
As the significant SNP is a tag, SNPs in LD of over r
2
 of over 80% are also 
considered significant. Table 4.5 gives information on the location of the tag 
SNP and identities of the SNPs in LD with the significant tag SNPs. 
 
Table 4-5: Significant tags SNPs from CA6. 
Of the 8 tags associated, 5 tag SNPs are 'singletons', meaning they represent 
no other SNP other than themselves. Whereas, the remaining 3 significant 
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SNPs have SNPs in LD with them which span different regions of the gene as 
shown in Fig 4.9. As the gene is too large, a portion of the gene crossing the 
5th exon is shown in the figure below. To note, E3' is a reported alternatively 
spliced exon which otherwise would be a part of the intron. 
 
Figure 4-9: Significant tags and associated SNPs of CA6. 
Abbreviations: 5' UTR- Untranslated region, E- Exon. 
4.3.5.1 Functional predictions 
Functional predictions for the significantly associated tags and SNPs in LD 
was conducted using the databases as mentioned in section 4.2.6. Depending 
on the location, SNPs were probed for different functions. The compiled 




Table 4-6: Functional predictions based on location of the SNPs. 
Abbreviations: E- Exon, Int- Intron, Y- Yes/ Present. 
Based on the above table, two regions i.e. the upstream and first intron were 
selected to probe for checking promoter-like activity. Due to the size 
limitation of the insert in the plasmid, two regions were selected for affecting 
splicing. The first region spanned exons 1,2,3',3,4 and the second construct 
spanned exons 2,3',3,4,5. As splicing was being checked by the construction 
of a minigene, exons along with 200 - 300 bases of the introns flanking the 
exons were joined together. 
4.3.5.2 Resequencing 
In HapMap, no SNPs with a MAF of 0.05 and above were found around the 
significant upstream tag (rs1409147) and in the introns flanking the second 
exon. Thus, resequencing was undertaken for this region to identify the 
different haplotypes present in our population.  
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A 5 kb region was successfully amplified using the long range high fidelity 
Kapa HiFi polymerase and areas of interest were sequenced.  The sequencing 
yielded the following LD pattern spanning upstream of the gene and from the 
first intron into the second intron (Figure 4.10). SNPs number 1-4 were 
upstream of the gene and SNP numbers 5-11 spanned intron 1, exon 2 and 
intron 2. SNP number 4 labelled as 'SNP1' was a novel SNP found, whereas 
the remaining 10 SNPs were reported SNPs in NCBI's SNP database. 
 
 




The numbers in the intersection of 2 SNPs represents the LD value in r
2
. 
Absolute black squares indicate perfect LD, i.e. r
2
 value of 100% between the 
2 SNPs as found in the case of SNP 8 (rs2274329) and SNP 9 (rs2274330).  
4.3.5.3 LD and haplotypes 
The upstream haplotype around SNP rs1409147 (SNP 3) identified through re-
sequencing is as shown in Fig 4.11 
 
 
Figure 4-11: Upstream haplotypes. 
The numbers 1 to 4 match with the previous figure (Figure 4.10). The boxed- 
haplotypes were selected for in vitro assay as their frequencies were above 
5%. 
The haplotypes for checking intron 1's promoter activity are as shown in 
Figure 4.12. SNP rs10864372 (SNP 5) was found to be present in SGVP in 
100% LD with the significant tag rs942969 and was thus incorporated in the 




Figure 4-12: LD pattern and haplotypes for the Intron 1 construct. 
The intron 1 construct for checking promoter activity was made with 6 SNPs 
as shown in Figure 4.12. As highlighted, three haplotypes present at a 
frequency of more than 5% were selected for  in vitro  activity. 
4.3.5.4 Luciferase reporter assay for promoter 
Two haplotypes for upstream construct probing for rs1409147 and three 
haplotypes for intron 1 construct probing for rs942969 were put through 
luciferase reporter promoter assay. The ratio of luminescence (normalised) 




Figure 4-13: Luciferase promoter assay for upstream haplotypes. 
The upstream construct showed promoter activity when compared to the 
empty vector in both cell lines. However, there was no difference observed 
between the two haplotypes (Figure 4.13). 
 
Figure 4-14: Luciferase promoter assay for intron 1 haplotypes. 
The intron 1 construct did not show any promoter activity as the three 
haplotypes have intensities similar to the vehicle control. Also, there was no 
difference between the three haplotypes (Figure 4.14) 
Thus the two regions probed for promoter activity showed no difference 
between haplotypes in the two tested cell lines. 
Similarly, to check for splicing around the other associated SNPs, 2 constructs 
were designed and ordered. 
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4.3.5.5 Minigene experiment for alternative splicing 
For the splicing minigene experiment, construct 1 spanning E1- E4 was 
designed as shown below. Eight haplotypes for this construct (minigene 1) 
were ordered as they were above 5% MAF. 
 
Figure 4-15: LD, haplotypes and construct for minigene1. 
Similarly, another construct spanning E2- E5 was designed as shown below in 
figure 4.16. Eight haplotypes for this construct (minigene 2) were ordered as 





Figure 4-16: LD, haplotypes and construct for minigene2. 
In vitro mini-gene experiment for splicing were conducted in HaCat and 
HEK2983T for both constructs with 8 haplotypes each. Experiment was done 
in triplicates, however, data was inconclusive (data not shown). 
 
4.4 Discussion 
CA6 had 8 tags associated with the disease. SNPs in LD with the significant 
SNPs ranged from upstream till after exon 5. To characterise the effect of 
these tags, exon array, methylation chips were run. Protein analysis and 
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physiological parameters of the skin were also investigated with respect to 
these SNPs. 
4.4.1 Alternative splicing 
 
More than 85% of SNPs found associated through GWAS and candidate gene 
studies are located in the introns or intergenic areas. SNPs in exonic areas are 
extremely few and with even fewer of those associated lead to change in 
amino acid. Even with a change in amino acid, extremely few of them actually 
lead to a drastically different amino acid with the possible outcome of altered 
protein function and stability. Similar trend of an overpowering number of 
associations found in intronic regions over exonic regions in our study 
corroborates the observed trends in literature. As a result, the large number 
and strong associations of intronic regions suggests a causal role in gene 
regulation to disease pathogenesis (Costa et al., 2013). A sizeable number of 
SNPs associated with the intron-exon boundary and exons (synonymous and 
non-synonymous) affect splicing, causing diseases (Krawczak et al., 2007). 
Given the diversity of known and still to be known mechanisms involved in 
splicing, alternative splicing may play a bigger role in disease pathogenesis. 
Results for gene expression and selective exon over-expression have been 
discussed in the context of the associated SNP in section 4.4.6. 
4.4.2 Regulation by DNA methylation 
DNA methylation is one of the major epigenetic regulator of gene expression. 
DNA methylation occurs in around 60-90% of the Cytosine-Guanine 
dinucleotides in mammals (Siegfried and Cedar, 1997). The link of DNA 
methylation and gene silencing is largely published and well accepted (Kass et 
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al., 1997; Keshet et al., 1985; Yisraeli et al., 1988). This repression is 
suggested to be due to the interference in the recognition and binding of 
transcription factors to the methylated DNA (Eden and Cedar, 1994). 
However, there are transcription factors which bind independent of the 
methylated state of the recognition sites. Another model suggests that 
methylated DNA attracts proteins which blocks access of different 
transcription induction factors (Boyes and Bird, 1991). Overall, a physical 
block placed either by the methyl-group or a protein bound to the methylated 
region causes repression. 
More recently, methylated regions found within the gene have been implicated 
in alternative splicing. Alternative splicing occurs when the weak splice sites 
compete with the stronger splice sites for being detected by the splicosome 
machinery (Matlin et al., 2005). This competition is regulated by (i) the 
presence of splicing factors which can detect enhancing and silencing 
sequences on the RNA and (ii) the rate of RNA polymerase II elongation (Han 
et al., 2011). Epigenetic markers such as methylation  add complexity to the 
DNA structure affecting the co-transcriptional processing of RNA. Recent 
studies have shown contrary effects of methylation such as (i) preventing 
binding of splicosome factors thereby causing exon skipping (Shukla et al., 
2011) and also (ii) enhancing exon recognition resulting in exon inclusion 
(Maunakea et al., 2013).  
With this in view, it can be concluded that methylation found upstream leads 
to transcription repression whereas methylation found within the gene could 
either promote in including or excluding the near-by exons. Results for 
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methylation associated gene repression and splicing have been discussed in the 
context of the associated SNP in section 4.4.6. 
4.4.3 CA6 protein levels 
Protein level difference were evaluated between 25 cases and 59 controls. No 
significant difference was observed between the two groups (P value = 0.780), 
however, cases did show a trend of lower levels in cases as compared to 
controls when observing the median levels (Fig 4.5). Protein levels were 
analysed with reference to genotypes of the associated SNPs. SNP rs1409147 
associated at the allelic level and lying upstream of the gene showed marginal 
association to protein levels (P value = 0.046) within cases. To further 
visualise the difference, data was plotted in a case-control manner (Fig 4.6). In 
the figure, the risk conferring allele B showed lower levels of protein in cases, 
while the same group had higher levels in controls. As AD is a complex and 
non-Mendelian disease, the effect of risk conferring allele is not absolute as 
depicted in Fig 4.6. Samples containing the risk conferring allele B with 
higher levels of the proteins constituted as controls, probably due to the 
protective alleles/genotypes of other associated SNPs. A similar trend was 
observed for SNP rs942969, however the difference was not significant (P 
value = 0.177). Protein levels in context with the associated SNPs and 
methylation has been discussed with greater detail in section 4.4.6. 
4.4.4 pH effect 
The acid mantle of the skin is a key regulator of maintaining homeostasis 
(Marchionini and Hausknecht, 1938). The usual pH is in the acidic region of 
5.4 - 5.9, with differences observed between gender, ethnicity and region of 
the skin (Braun-Falco and Korting, 1986). Increase in pH has been shown to 
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be associated with eczema (Eberlein-Konig et al., 2000) and also cause barrier 
dysfunction (Hachem et al., 2003). Serine proteases involved in desquamation 
have an optimum activity at neutral pH (Ekholm et al., 2000), thus the acidic 
pH keeps the activity under control. An increased pH could send these 
proteases in hyper drive causing barrier dysfunction. Increased pH also 
reduces the activity of lipid synthesizing enzymes (Holleran et al., 1993). 
Also, methods such as tape stripping have been known to disrupt the barrier 
(Bashir et al., 2001) causing an increase in pH (Dikstein and Zlotogorski, 
1994; Ohman and Vahlquist, 1994). Moreover, increased pH is shown to delay 
barrier recovery (Mauro et al., 1998). Results for the pH association data to 
the significant SNPs has been discussed in section 4.4.6. 
4.4.5 TEWL 
Trans-epidermal water loss is a measure of the permeability barrier of the skin. 
Higher TEWL reading indicates increased rate of evaporation (Fluhr et al., 
2006). This can be due to an inherent defective permeability barrier or due to 
external physical stress such as tape stripping or scratching. Increased TEWL 
readings has been shown to be negatively correlated with skin hydration and 
positively correlated to a few proteases of the SC (Voegeli et al., 2008). 
TEWL is also shown to be associated with thickness of the barrier (Nikolovski 
et al., 2008). Results for TEWL association data to the significant SNPs has 





With the above information and discussion in view, the associated SNPs are 
discussed below.  
4.4.6.1 rs1409147 
The upstream SNP rs1409147 is associated with the disease state through 
allele B. Exon array data showed the BB genotype had reduced expression of 
the probe in the upstream region. This could imply a reduction in the 
transcription in presence of BB. Also, CA6 protein levels showed that BB in 
cases had significantly low levels as compared to AA+AB genotypes, and this 
trend is reversed in the control group. These results hint towards a reduced 
expression of CA6 when associated with BB genotype of rs1409147. When 
analysing methylation differences between case and control, methylation site 
upstream of the gene was found to be slightly more methylated in cases than in 
controls. Methylation upstream is correlated with gene silencing or reduced 
gene expression. Functional prediction of the SNP had shown presence of 
transcription factor binding site thereby strengthening the association of 
rs1409147 to the expression levels of CA6. In vitro luciferase reporter 
experiment also showed the presence of a promoter activity, although no 
difference between the haplotypes was observed. Even though in vitro 
experiments did not show a difference between the haplotypes, the remaining 
data strongly suggests the risk allele of rs1409147 to have reduced overall 
expression of CA6. In vitro demonstration may have failed due to the possible 
lack of the specific transcription factor which might have the ability to 




 rs942969 present in intron 1 is associated with AD by B allele and BB 
genotype as compared to AA. rs942969 is in LD with SNPs further in the 
intron 1 and 1 SNP in intron 2 which maps onto an alternatively spliced exon 
referred to as E3' in this chapter. Functional prediction for the rs942969 and 
the SNPs in LD with it showed putative regulation by transcription factor and 
a possible splicing effect. To evaluate the functional prediction, haplotypes 
present in the first intron were tested through luciferase promoter assay. 
However, the construct did not shown any promoter activity as compared to 
the vehicle control. With this, it can be concluded that rs942969 is not 
associated through transcription based regulation. Methylation based study 
revealed low methylationin in the region E1 associated with the risk-
conferring BB genotype. Methylation with the gene has been shown to affect 
splicing. Thus, it can be concluded that rs942969 regulates CA6 via 
methylation. However, the exact effect of the methylation still needs to be 
ascertained.  
4.4.6.3 rs2274327 
SNP rs2274327 present in exon 2 is associated with AD through the A allele 
and through AB genotype when compared against BB. Besides a predictive 
effect on splicing, rs2274327 causes a change of amino acid from Threonine 
to Methionine at 55th amino acid position. On discussing with a structural 
biologist, it was suggested that the variant lying on an exposed helix may alter 
the stability of the protein. Protein stability of the two variants in different salt 
and pH conditions are planned to be checked through circular dichroism in the 
near future. Methylation study found the probe present between E6 and E7 to 
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be more methylated with the risk genotype of AB indicating a possible role in 
splicing. 
4.4.6.4 rs2274328 
rs2274328 is associated with AD through allele B and through AB genotype 
when compared with AA. This SNP also lies in exon 2 and causes a change 
from Methionine to Leucine at amino acid position 68. Structural evaluation 
would be needed to check if the change affects the structure or activity in 
anyway. The risk-conferring genotype AB was shown to be associated with 
CA6 over-expression. AB was also found to be associated with increased 
transcription of exon 1 and exon 9. Methylation study also showed AB was 
associated with higher methylation in the region between E5 and E6 indicating 
its possible role in splicing.  
4.4.6.5 rs11576766 
SNP rs11576766 shows a similar trend as rs2274328. The AB genotype has a 
risk effect as compared to AA and BB and was shown to have higher gene 
expression in the risk genotype group. AB was also found associated with 
enhance transcription of upstream, exon 9 and 3' UTR. The AB genotype 
showed significantly higher levels of methylation as compared to AA and a 
trend of higher methylation as compared to BB for the upstream methylation 
site. This suggests, that reduced gene expression as a result of methylation of 
upstream regions is associated with AD cases. This follows the same trend of 
the upstream SNP rs1409147. Higher methylation between E5 and E6 is 
observed in AB as compared to AA again suggesting a possible role in 
splicing of the exons around that region. Thus rs11576766 seems to regulate 
gene in two very different ways via methylation. Another interesting 
134 
 
observation was the increased pH after a physical stress in the AB genotype. 
This suggests an inherent aberration in the processes involved in maintaining 
homeostasis as in AD. Based on literature explained earlier, this group would 
have a slower recovery leaving their skin open to allergens and pathogens for 
a longer time thus predisposing to AD.  
4.4.6.6 rs17032921 
rs17032921 lying in the intron 2 of the gene represents 5 SNPs  based on LD. 
The SNPs in LD are present in intron 2, intron 4 and intron 5. rs17032921 is 
associated with AD through allele A and genotype AA as compared to BB. 
Although predicted to have an effect on splicing, there was no differential 
expression of exons observed. In the methylation study, no sample with AA 
genotype was assayed due to the small numbers. However, AB showed  
significant lower methylation as compared to BB for the regions between E5 
and E6 (intron 5). This indicates a possible regulation of alternative splicing 
due to methylation. 
4.4.6.7 rs754200 
SNP rs7545200 present in intron 3 is a singleton SNP associated with AD 
through the allele A. This SNP was found to be associated with increased pH 
in general and with increased pH prior to tape stripping in the AB genotype 
over BB, and AA+AB versus BB genotypes (data not shown). The increased 
pH  as with rs11576766 is a marker for dysfunctional barrier. The risk group 
(AA+AB)  has a higher pH as compared to BB similar to that observed in 
people with AD. The risk conferring group (AA+AB) showed a marginal 
decrease in TEWL as compared to BB genotype. Although increased TEWL is 
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the hallmark of AD, it is highly variable upon ambient conditions and physical 
condition of the skin due to scratching or rubbing. 
4.4.6.8 rs3765965 
rs3765965 lying in the intron 4 is associated with AD through BB genotype as 
compared to AA. No samples from the minor genotype BB were put through 
methylation, thus an analysis of AB versus AA was done. AB genotype 
showed lower methylation associated with the area between E5 and E6 as 
compared to AA. This could link the putative function of rs3765965 splicing 
regulated by methylation. 
Overall, all the associated 8 tags were attributed to some function thereby 
strengthening the results of the association study. Different SNPs contributed 
to the pathogenic model in different ways. For eg: rs1409147, differences 
between case-control and upstream methylation by rs11576766 showed 
suppressed expression of CA6 to be associated with AD. However, gene 
expression associated with rs2274328 and rs11576766 show increased 
expression in the risk genotype. This shows, different mechanisms at play 
having contradictory effect. This may be the reason why no difference in CA6 
protein levels were observed between the well powered case-control study.  
4.4.7 Carbonic anhydrase VI 
CA6 also known as gustin is a secreted form of carbonic anhydrase. It is a zinc 
metalloprotein which is thought to catalyse the hydration of carbon dioxide in 
regulating pH (Carter, 1972; Khalifah, 1971b). 







Carbonic anhydrases are involved in maintaining cellular pH, water transport 
and ion homeostasis (Nakhoul et al., 1998). CA6 is abundantly found in saliva 
(Fernley et al., 1979), milk (Karhumaa et al., 2001), gut (Parkkila et al., 1994) 
and other epidermal tissues. It is hypothesized to have a mucosa protective 
role in the gastro-intestinal tract of neonates, as the colostrum has 8 times 
more CA6 than mature milk and saliva (Karhumaa et al., 2001). It is also 
thought to be a growth factor for taste-buds. SNP rs2274327, significant in our 
study,  has been shown to increase buffering capacity of the saliva (Peres et 
al., 2010).  
CA2 a member from the same family was shown to be up-regulated in AD 
skin biopsies when compared with psoriatic and normal skin. The group also 
found CA2 to be inducible by Th2 cytokines in keratinocytes (Kamsteeg et al., 
2007). The up-regulation of CA2 doesn't seem to be genetic as we found no 
association for CA2 in our genetic study. Also, inhibition of CAs has been 
shown to lower intracellular pH (Kniep et al., 2006).  
A fine balance in the pH is required to optimally activate the proteases and 
their inhibitors, an aberration in which can over process the inactive proteases 
thereby causing barrier dysfunction. Proteases, besides degrading the 
corneodesmosomes and lipid producing enzymes, also aid in the downstream 
over-expression of pro-inflammatory cytokines such as IL-1α, IL-1β, TNF- α 
and IL-6 (Wood et al., 1996; Wood et al., 1997). pH is also believed to play 
an important role in maintaining the normal flora of the skin by favouring 
adhesion of non-pathogenic bacteria (Bibel et al., 1987) and preventing 
colonisation of pathogenic microbes (Rebell et al., 1950). Thus, pH seems to 
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be the master regulator of all the key processes involved in maintaining the 
epidermal barrier. Consequently, a novel association of a possible pH 
regulating gene (CA6) to the pathogenesis of AD is an important discovery 
and paves the way for more detailed therapeutic research of pH control. 
Since its discovery in 1940s, not much is known about the true function of 
CA6 (Sly and Hu, 1995). Its presence, regulation and similarities with other 
members have resulted in most of the hypotheses for its function. This study in 
addition with the other cited above further stress the importance for detailed 
research of this gene. 
 
4.5 Conclusion 
Association of the CA6 to the disease was established through genotyping 
study. Association of the significant SNPs to methylation- regulated and 
alternative splicing was also established. However, in vitro characterisation of 
the associations still needs more work. Defined gene function of CA6 which is 
still elusive after years of discovery would be needed in order to  bridge the 




Chapter 5  
Replication studies  
5.1 Validation of Han Chinese AD GWAS in 
Singapore population. 
 
Part of this chapter is published in Journal of Investigative Dermatology 
(2012) titled, 'Validation of GWAS loci for atopic dermatitis in a Singapore 
Chinese population' 
5.1.1 Introduction 
Candidate gene study approach for identifying genes associated with a disease 
relies on a priori hypothesis for the disease model. As in this thesis, pathways 
or members of protein families or genes expressed and localised at the disease 
site are few of the starting points for initiating a candidate gene study. 
However, the genome wide association studies (GWAS), is a hypothesis 
generating study wherein no prior information on likely candidates is needed. 
Study design and a well powered sample size are the initial stages of a GWAS 
with the results giving leads to the possible pathways at play. With high 
throughput and low cost, GWAS for complex diseases is affordable to labs.  
One of the major bottle-necks to a successful GWAS are large numbers. 
Power curves have shown that to obtain a modest effect size of OR 1.3 for 
SNPs with a MAF of less than 0.1, sample sizes in thousands is needed (Wang 
et al., 2005). The large number of probed SNPs results in an even higher rate 
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of false positives. To be able to discern the difference between the true and 
false positives (Wacholder et al., 2004), multiple corrections for such a high 
number of probed SNPs leads to a p value cut off that many studies fail to 
cross. 
GWAS for AD have yielded novel candidates in the recent past. In 2009, a 
new candidate on chromosome 11q13.5, C11orf30 was discovered in 
European populations. The study's discovery set comprised of 939 cases and 
975 controls and 270 nuclear families and the significant SNP was validated 
on 2637 cases and 3957 controls. The study found a SNP rs7927894 which 
was 38kb downstream to C11orf30. Around 13% with an European ancestry 
carry the homozygous variant of this SNP and showed an OR of 1.47 
(Esparza-Gordillo et al., 2009).  GWAS in Japanese population identified 8 
new loci - IL1RL1-IL18R1-IL18RAP, MHC region, OR10A3-NLRP10, GLB1, 
CCDC80, CARD11, ZNF365 and CYP24A1-PFDN4 from a population of 
3328 cases and 14992 controls (Hirota et al., 2012). Another discovery study 
on 1536 cases and 4054 controls and a validation on 2286 cases and 3160 
controls of European ancestry resulted in regions;  (i) of the epidermal 
differentiation complex on chromosome1,  (ii) around LRRC32 on 
chromosome 11, (iii) around RAD50/IL13 locus on chromosome 5 and (iv) 
around MHC on chromosome 6 (Weidinger et al., 2013). GWAS conducted 
on canines have also resulted in interesting candidates such as SORCS2, 
RAB3C and PROM1 (Wood et al., 2009) and PKP2 (Tengvall et al., 2013). 
The only GWAS on a Chinese (Han Chinese) population was published in 
2011. The initial study was on 1012 cases and 1362 controls which was then 
validated on a 3624 cases and 12197 controls of the same ethnicity and 
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replicated on 1806 cases and 3256 controls from Germany. They found and 
validated 2 new loci in chromosome 5q22.1 (rs7701890) and 20q13.33 
(rs6010620). They replicated the 1q21.3 locus (FLG rs3126085) and provided 
suggestive association at 10q21.2 (rs2393903) (Sun et al., 2011). With the 
inability to match their sample size and a close genetic link of  the Singapore 
Chinese with ethnic Han Chinese, we decided to validate the 3 SNPs from the 
Chinese AD GWAS results in our population. 
5.1.2 Materials and method: 
The samples used for this study overlapped with those described in Chapter 2 
and Chapter 3 (NUS + KKH + IMB/NSC). In addition 400 Singapore Chinese 
controls were ascertained from Bio Bank as population controls (Common et 
al., 2011). A total of 827 AD cases and 1104 controls were genotyped.  
Genotyping for the 3 SNPs was conducted by using TaqMan assays according 
to manufacturer's protocol.  
5.1.3 Results: 
The genotyping results are summarised below. The chromosome 10 
(rs2393903) and chromosome 20 (rs60110620) SNPs were found associated 
with AD in our population. The effect sizes as described by the OR are similar 
to the Chinese GWAS study. SNP found on chromosome 5 (rs77018980) 




Table 5-1: Case control association for AD GWAS SNPs. 
Data was also analysed by splitting the AD cases into those with AD alone 
(AD only) and those with either asthma or AR or both (AD+ others), as 
defined in Chapter 2. Results showed a significantly stronger association of 
risk C allele of the chromosome 10's SNP in AD alone when compared with 
AD and other atopic conditions (OR 1.45 vs 1.2). 
On a subset of the population collected from National Skin Centre through 
IMB, severity scores were collected through SCORing Atopic Dermatitis 




Figure 5-1: Distribution of SCORAD scores vs genotypes. 
ANOVA analysis showed a difference for chromosome 10 SNP (rs2393903) 
with the CC genotype group (mean 33.99±1.568; n=94) having lower 
SCORAD scores as compared to CT (mean 39.48±1.043, n=197; t-test, 
P=.0034) and TT (mean 40.66±1.491, n=98; t-test, P=0.0023) (Figure 5.1). 
The results suggest rs2393903 is associated with milder form of AD whereas 
the other SNPs showed no association to severity based on SCORAD scores. 
In order to evaluate the lack of association on chromosome 5  (rs7701890), we 
tested the various parameters evaluated in Chapter 2 using logistic regression 
on the samples collected from NUS (432 cases and 700 controls). We 
observed a significant association with household income (P= 0.017), in 
which the minor allele G showed the trend of a risk effect [OR = 1.22 (95% CI 
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0.92–1.61), P=0.17] in the low-income group (<S$4,000 a month) and a 
protective trend [OR = 0.71 (95% CI 0.49–1.01), P= 0.06] in high-income 
group (> S$4,000 a month).  
5.1.4 Discussion 
We validated the chromosome 10 (rs2393903) and chromosome 20 
(rs60110620) SNPs' association in our population, however, rs7701890 from 
chromosome 5 (rs7701890) could not be replicated. Previous studies in the 
Asian region have shown a reduced prevalence of allergic diseases in lower 
income groups in Singapore (Goh et al., 1996) and Hong Kong (Lau et al., 
1995). However, more recently, increased prevalence of eczema in lower 
income had been reported in the United States (Hanifin and Reed, 2007). This 
highlights the change and impact of environmental factors that can become 
possible confounders in future studies. We speculate that higher percentage of 
subjects from a high-income group in the Singapore Chinese population 
compared with the subjects from the Chinese GWAS study may explain the 
lack of association on chromosome 5.  
5.1.5 Conclusion 
We validated the reported strong association at chr10q21.2 and a weaker one 
at 20q13.33 with AD among Singapore Chinese, but suggest the genetic 
association at 5q22.1 might be influenced by the interaction with 
environmental factors. The validation of new AD loci will help to further 
understand the genetic basis of this complex disease. However, a much larger 
sample size would need to be examined to scrutinise the effect of non-genetic 
interaction to disease (Andiappan et al., 2012). 
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5.2 Association of FLG mutations 
5.2.1 Introduction: 
As indicated in section 1.7, FLG  is the most widely associated gene to atopic 
dermatitis (Palmer et al., 2006). It forms a part of the tough barrier by 
collapsing the aggregated fibres forming the flattened large surface of the 
corneocytes (Candi et al., 2005). The FLG protein also deaminated to form 
free amino acids which are then catabolized into the constituents of water-
retaining natural moisturising factor (NMF). Water retention within 
corneocytes results in their optimal hydration and swelling, which prevents the 
development of gaps thereby enhancing the integrity of the SC and making it 
resistant to the penetration of irritants and allergens (Elias et al., 2008). NMFs 
like trans-urocanic acid and pyrrolidone carboxylic acid are also suggested to 
play a role in balancing the acidic skin pH. Acidic pH besides regulating the 
desquamation process, helps to maintain a healthy microbial flora of the skin 
(Bibel et al., 1987; Rebell et al., 1950).  
Of the many mutations reported, two most common loss-of-function mutations 
(R501X and 2282del4) account for the majority of AD cases in European 
populations. In Japanese population as well, FLG has been shown associated 
with AD, however, a different profile of FLG markers seems to exist in 
different populations (Osawa et al., 2010). FLG's wider variant landscape was 
further highlighted with an exhaustive discovery search in the Singapore 
Chinese population where 22 null mutations, 14 of which were novel, were 
discovered (Chen et al., 2011). Chen et al found different combinations of 
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these 22 null mutations associated with AD in the Singapore Chinese 
population ascertained from the National Skin Centre.  
A collaborative project was initiated to check the association of the 6 common 
FLG mutations which represented 72% of the FLG mutation profile in 
Singapore.  
5.2.2 Materials and method 
Samples from the NUS cohort were assayed for the 6 common FLG mutants. 
A total of 700 Singapore Chinese samples were typed. 5 sample failed QC and 
the remaining 662 AD cases and 33 controls were assayed by Huijia Chen at 
IMB according to their standardised methods (Chen et al., 2011). The few 
number of controls were increased by adding the 440 control samples data 
presented in the Chen et al paper. Cases were further split into severity and 
chronicity and analysed versus controls. Fishers exact test was used to test for 
associations. 
5.2.3 Results 
The six common FLG mutations found in Singapore were kindly assayed by 
IMB. Due to the limitation in the number of samples that could be processed 
by them, we sent all the cases collected as of then and made up the remaining 




Table 5-2: Case control association for FLG mutations. 
Paper = Chen et al, 2011 paper 
To conduct a case-control association study, control numbers from the Chen et 
al paper were used, as their population was also Singapore Chinese. Of the 6 
mutations assayed, 3 were newly discovered for the paper (Chen et al., 2011). 
All of the 6 mutations except p.S2706X were found associated with AD in the 
National Skin Centre cohort. However, only 1 previously known mutation, 
p.E2422X was found associated in the NUS cohort. 
 
Table 5-3: Association based on severity and chronicity. 
To test the lack of mutation at other positions, cases were divided based on 
severity and chronicity. The division criteria was identical to section 3.2.2. 
The results for the association are tabulated above (Table 5.3). pE2422X 
associated at the case control level of analyses (P value= 0.046) was found to 
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be significantly associated  in mild (P =0.041) and  in moderate (P =0.023) 
cases versus controls. This null mutation was also found associated in chronic 
AD cases. 
Two other mutations (c.3321delA, p.Q2417X) were also found associated with 
chronic AD cases when compared to controls. 
5.2.4 Discussion 
Of the six tested mutations, only 1 (pE2422X ) could be replicated in our 
cohort. The association for pE2422X showed an increasing trend of 
association from mild to moderate cases. However, no association to severe 
cases from NUS was found. This may have been due to the small sample size 
of 84 severe AD cases versus 473 controls.  
The differences in association observed between Chen et al study and NUS 
cohort may be attributed to the different ascertainment procedure. Samples 
from NSC (Chen et al., 2011) were from clinics where the people were 
afflicted enough at the time to see the doctor. They also had other 
dermatological conditions such as ichthyosis vulgaris, keratosis pilaris and a 
very high percentage of severe AD (40%) and a low mild AD (6%) (Chen et 
al., 2011).  Whereas our cohort was collected at the population level with a 
very high rate of mild and non-chronic AD. This point is further corroborated 
with the emergence of associations at c.3321delA, p.Q2417X in chronic cases. 
5.2.5 Conclusion 
 FLG one of the most widely associated gene to AD and ichthyosis vulgaris, is 
associated with more severe and persistent forms of AD. Milder forms of AD 
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collected at a population level may have different genes at play in their 




Chapter 6  
 




"If you can't explain it simply,  
you don't understand it well enough." 
-Albert Einstein 
6.1 Conclusions 
Atopic dermatitis, commonly known as eczema, is a chronic itchy skin 
condition with an increased incidence of occurrence at skin fold. It is a highly 
complex disease with a strong genetic and environment component in its 
pathogenesis. Changing environment associated with industrialisation is 
positively correlated to AD resulting in a diversity of its prevalence across the 
globe. With passage of time, different hypotheses for its pathogenesis have 
gained acceptance. Atopy, described as an IgE-antibody high responder to 
innocuous agents, was earlier thought to be the causative mechanism. Newer 
hypothesis of a dysfunctional barrier started gaining acceptance in the mid 
1990's. This lead to the wider acceptance of the combination of atopy and 
barrier property related pathways with a dysfunctional barrier as the primary 
step. Chapter 1 describes the different views pertaining to this ideology and 
briefly explains the variety of ways the skin maintains homeostasis and its 
barrier properties, thus, laying the background for subsequent chapters. 
In chapter 2 an epidemiological study for eczema in Singapore is explained. 
This study was done to evaluate the changes since the last 2 published studies. 
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The comparisons show an increase in prevalence for eczema over the years 
attributable to strong non-genetic factors (Goh et al., 1996; Tay et al., 2002; 
Wang et al., 2004). Other parameters of the questionnaire were tested to assess 
for associations and possible risk factors. Factors such as gender, race and age 
showed positive association to AD and thus other variables were evaluated 
after controlling for their confounding effect. Paternal eczema was found to be 
the strongest association followed by maternal eczema and family history of 
atopic conditions-- clearly highlighting that AD is strongly linked to genetics 
and atopy is involved in its pathogenesis. 
With the knowledge of genetics as a major contributing factor, we set out to 
identify barrier-related genes associated with AD in ethnic Chinese. The 
population ascertained for the epidemiology provided a good sample source 
for a case-control association study. Direct or indirect barrier related genes 
were screened and validated through a 2-stage study designed to identify the 
genes and their risk conferring SNPs. To better discern the results, analyses for 
chronicity, severity, against SPT positives and controlling for confounding 
demographic stratifications were conducted. The results showed 27 genes 
associated with AD of them most were directly linked to barrier maintenance 
and the remaining through either atopy or autoallergy as described in Chapter 
3. 
After finding a set of barrier related genes associated with AD, we decided to 
further characterise the risk conferring SNPs. For the same, CA6 was selected 
for further characterisation as described in detail in chapter 4. Eight tags were 
found associated with the minor allele of 2 SNPs conferring a protective role 
and that of the remaining 6 conferring risk. Associations of genotypes of these 
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SNPs to gene expression levels and specific probes for exons were checked 
independent of disease status. Associations to gene expression and splicing 
were observed which showed increased gene expression in the risk genotype. 
However, translated CA6 protein level which is downstream of gene 
expression and alternative splicing did not show any difference between cases 
and controls. To evaluate if the SNPs are involved in epigenetic regulation, 
methylation study was conducted. SNPs were found to be associated with 
differential methylation pattern when segregated according to genotypes. 
Increased methylation was found upstream of the gene which is indicative of 
gene silencing (Keshet et al., 1985). Thus risk genotypes of different SNPs 
exerted contradictory effects on gene expression which may have been the 
reason for the lack of CA6 protein level difference between cases and controls. 
Differential methylation was also observed within the gene when segregated 
according to SNP genotypes. These SNPs were present in the intron-exon 
boundaries and may affect the alternative splicing of CA6. It has been recently 
shown that methylation within the gene can affect splicing by either promoting 
exon inclusion (Maunakea et al., 2013) or exclusion (Shukla et al., 2011). 
Thus, the associated SNPs of CA6 were linked to either gene expression and 
alternative splicing through differential methylation. As CA6 is hypothesized 
to affect the pH which in-turn maintains the barrier homeostasis, relevant 
parameter such as skin pH was measured. Risk conferring genotype of a SNP 
was found associated with increased pH. Increase in pH has been previously 
associated with AD (Eberlein-Konig et al., 2000). Increased pH has been 
shown to be the cause (Holleran et al., 1993) and the effect (Dikstein and 
Zlotogorski, 1994; Ohman and Vahlquist, 1994) of barrier dysfunction thereby 
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strengthening the association. As all these associations were at the ex vivo 
level, in vitro experiments containing the prevalent haplotypes were initiated. 
Although, no difference between haplotypes were observed for the luciferase-
reporter promoter assay, minigene experiment for checking splicing needs 
further work. 
This thesis identified and validated few novel and many previously associated 
candidates to AD which can be pursued for functional characterisation. CA6, a 
gene never studied in the context of skin before, is an interesting discovery as 
it is hypothesized to regulate pH which is the master controller of all barrier 
processes in the epidermis. Also, this gene has 8 independent signals of 
association. Functional characterisation of the risk variants to change in gene-
function and then ultimately to its involvement in disease pathogenesis may 
make this the next big candidate after FLG. 
Chapter 5 gives a brief account of the replication studies conducted on our 
cohort. The Chinese GWAS SNPs were validated on our population and hints 
of a possible socio-economic confounder emerged from this work which 
resulted in a paper (Andiappan et al., 2012). Chen et al discovered a different 
spectrum of FLG mutations in the Singapore population and found its 
association to AD in cases ascertained from National Skin Centre (Chen et al., 
2011). Although the common variants were not significantly associated with 
AD (except one) in our cohort, stratifying our samples based on chronicity and 
severity showed newer and increased trends of association. This suggests that 
FLG is associated with the more severe and chronic forms of AD and is 
probably not one of the best descriptors for milder forms of AD. 
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This thesis has highlighted the importance of other barrier maintaining genes 
besides FLG which are involved in pathogenesis of AD. Knowledge of this 
can be used to probably make a diagnostic chip of the significant SNPs. Also, 
the genes found associated will pave way for future research into their 
respective pathogenic mechanisms. In future, this might form the basis for 
therapeutic research and formulations. 
6.2 Future work and implications 
Twenty seven genes identified and validated to be associated with AD can 
form 27 different major projects of future research. In the context of CA6, 
collaborative efforts to replicate associations in different population would be 
important to further establish CA6 as an important AD candidate.  
A larger cohort with pH and TEWL measurements would need to be 
ascertained to increase the representation of the homozygous minor genotypes 
thereby making the analysis more robust. 
Results obtained from different array data-sets would need to be validated by 
using another platform/technique. Methylation array results would need to be 
validated on a larger population and by using a different platform. QIAGEN 
offers assays for validating HumanMethlation450K BeadChip data by 
pyrosequencing. Alternatively, sequencing after bisulphite conversion can also 
be adopted (Frommer et al., 1992). Results obtained from the exome array 
would have to be validated using real-time PCR. In vitro  splicing studies 
using mini-genes (Gaildrat et al., 2010) would help to corroborate the exome 
and gene expression results from the array. Splicing experiments done in 
presence of; 5-aza-2'-deoxycytidine, a DNA methylation inhibitor (Christman, 
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2002) and methotrexate, methylation enhancer (Dinh et al., 2013) would help 
identify the exons included and or excluded due to the risk conferring 
haplotypes. This would help identify the alternatively spliced variants enriched 
through different haplotypes under the regulatory effect of methylation. 
To carefully tease out the effects of the selectively spliced forms, stable cell 
lines expressing these variants could be constructed. Measurements such as 
total expressed CA6 protein could be measured to validate the effect  on 
expression levels. Further physiologically relevant experiments such as wound 
healing (Liang et al., 2007) could be conducted on these stable cell lines. 
Measurements such as trans-epithelial electrical resistance, a measure of 
permeability of the monolayer could be conducted (Ebihara et al., 2005). 
Alternatively, a labelled solute flux assay could be used to again test for the 
integrity of the monolayer containing the risk variants (Chandra et al., 2007).  
The stable cell lines could also be used to detect a change in pH by using 
different adapter to the skin pH meter. If a difference in pH and monolayer 
integrity is observed then the intermediate pathways amounting to the 
observation could be evaluated. Over expressing and silenced cells for CA6 
could be analysed for gene expression and different genes up or down-
regulated could be then examined for their role in pathway leading to barrier 
defect and or change in pH. 
Also, organotypic models can be created for the CA6 variants for future basic 
and therapeutic research (Oh et al., 2013). Our collaborators at IMB have the 
expertise in constructing 3D skin models which can be used for a whole set of 
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Appendix: Survey questionnaire 
 
Date: ________________  Sample ID: _________  
 
A Survey on Breathing, Nose and Skin Problems 




Full Name: ____________________________________________________________________      Gender:  M     F 
Matriculation/Staff No.: _________________________   Age: _______    Date of birth: _________________(dd/mm/yy) 
Race: Chinese Malay Indian Other: __________________(please indicate)  
Country of birth:  Singapore         Other: ________________ (please indicate). No. of years in Singapore: _______ 
Type of Housing:  HDB        Condominium / Private Apartments Landed Property 
Total monthly family income:     Below $2000       $2000-3999         $4000-5999         $6000 and above 
Number of people in household (including yourself): ______ 
Postal code: __________ Contact No.:_________________ Email:__________________________________ 
 
General Medical History 
 
 
1. Weight (in Kg): ___________________ Height (in cm): ______________________ 
2a. Do you have any drug allergies        Yes No 
IF YOU HAVE ANSWERED “NO”, PLEASE SKIP TO THE NEXT QUESTION 
 
2b Are you allergic to any of the following drugs? 
 
Aspirin     Yes No 
Ibuprofen    Yes No 
Voltaren    Yes No 
Other pain medication  Yes No 
Other drugs   Yes No If Yes, please indicate:______________________ 
 
3. Have you been prescribed any of the following medications by your doctor? 
 
  Antihistamines (e.g. Loratidine, Cetrizine, Chlorpheiramine)   
  Bronchodilators (e.g. Salbutamol, Terbutaline, Atrovent)   
  Inhaled steroids (e.g. Belomethasone, Budesonide, Fluticasone, Inflammide, etc)  
  Oral steroids (e.g. Prednisolone)     
  Nasal spray (e.g. Nasonex, Flixonase) 
  Topical steroids (e.g. Hydrocortisone, Betamethasone Valerate, Mometasone) 
  Antibiotic ointments (e.g. Neomycin) 
  Moisturizers / Emollients  














4. Have you ever been told by a doctor that you have had Hepatitis A Virus (HAV) Infection? 
 
Yes No 











2. Have you had wheezing or whistling in the chest in the last 12 months? 
 





3. How many attacks of wheezing have you had in the last 12 months?   None 
   
 
4 t  12  
More than 12 
1 to 3 
 
4. In the past 12 months, how often, on average, has your sleep been disturbed due to wheezing? 
Never woken with wheezing  
Less than one night per week  
One or more nights per week  
 
5. In the last 12 months, has wheezing ever been severe enough to limit your speech to only one or 





6. Have you ever had asthma?  Yes No 
 
 
7. At what age did you first have asthma? (age) __________ 
 
 
8. For how many years did you have asthma? (years) __________ 
 
 






10. In the past 12 months, have you had a dry cough at night, apart from a cough associated with a 












If you had asthma in the past 12 months, please answer the following questions.  
If you have “NO” asthma, please skip this section and go to Section III 
 
 
1. In the past 12 months, how often, on average, have you experienced asthma attacks in the daytime? 
Not at all  
Less frequently than monthly  
1-3 times a month  
1-3 times a week  
4-6 times a week  
Every day  
 
2. In the past 12 months, how often, on average, have you experienced asthma attacks at night? 
Not at all  
Less frequently than monthly  
1-3 times a month  
1-3 times a week  
4-6 times a week  
Every day  
 
 
3. In the past 12 months, how many days (or part days) of school have you missed because of 
wheezing or asthma? 
 
None 
1 to 5 days  
6 to 10 days  
More than 10 days 
 
 
4. In the past 12 months, how many times have you visited a General Practitioner’s clinic or 






1 to 3 visits  
4 to 12 visits  
More than 12 visits  
5. In the past 12 months, how many times have you visited the Accident & Emergency 
Department in any hospital for asthma (e.g. a wheezy episode and regular asthma checkup)?  None  
 
None  
1 to 3 visits  
4 to 12 visits  
More than 12 visits  
 
 
6. In the past 12 months, how many times have you been admitted to hospital because of wheezing or asthma?  
  None  
1 to 3 times  
4 to 6 times  
7 or more  
 
  












2. In the past 12 months, have you ever had a problem with sneezing or a runny or blocked nose when you DID 












4. In the past 12 months, have you had any of the following symptoms when you DID NOT have a cold or flu?  
 
PLEASE INDICATE IF YOU HAVE THE FOLLOWING SYMPTOMS (4a), HOW OFTEN YOU HAVE THEM IN A WEEK (4b), FOR HOW MANY 
CONSECUTIVE WEEKS YOU HAVE THE SYMPTOMS (4c), AND HOW SEVERE THE SYMPTOMS ARE (4d) 
 




Yes or No 
≤ 3 days 
per week 
≥ 4 days 
per week 
≤ 3  
weeks 
≥ 4  
weeks 
Severity of symptoms* 
0 1 2 3 
 














    
 
Sneezing Yes No         
 
Runny nose Yes No         
 
Nose blockage Yes No         
 
Snore Yes No         
 
Nose bleed Yes No         
 
* 0 = none: no symptom evident;  
1 = mild: symptom clearly present but minimal awareness;  
2 = moderate: definite awareness of symptom which is bothersome but tolerable;  
3 = severe: symptom is hard to tolerate and causing interference with activities of daily life/sleeping. 
 






6.  How long have you been living with these nose symptoms?  
 
Sleep disturbance  
Impairment of daily activities. Leisure and/or sport  
Impairment of school or work  
Troublesome symptoms  
 
Less than one year 
 
 
1-4 years  
5-10 years  
10 or more years  
 
7.  Have you ever had allergic rhinitis?  Yes   No    Don’t know 
 
  



















3.  Has this itchy rash at any time affected any of the following places: 
The folds of the elbows, behind the knees, in front of the ankles, under the buttocks, or around 
the neck, cheeks, ears or eyes? 
 





4.  At which age did this itchy rash first occur? 
 
 
Under 2 year 
Age 2-4 years 
Age 5 or more 
Don’t Know 
 





6.  In the past 12 months, how often, on average, have you been kept awake at 
night by this itchy rash? 
 
 
Never in the last 12 months 
Less than one night per  week 
One or more nights per week 
7.  In the past 12 months, have you suffered from dry skin? Yes 
No 











1. In the past 12 months, how often, on average, did you eat or drink the following?  
 
 Never or Only 
occasionally 




Meat (e.g. Beef, lamb, chicken, pork)     
Seafood (including fish)      
Fruits     
Vegetables (green and root)      
Pulses (peas, beans, lentils)      
Cereals (including bread)      
Pasta     
Rice     
Butter     
Margarine     
Nuts     
Potatoes     
Milk     
Eggs     
Burgers / fast food     
Yakult / Vitagen / similar yogurt drinks     
 
 
2. How many times a week do you engage in vigorous physical activity long 
enough to make you breathe hard? 
 
Once or twice per week 
Most or all days 
Never or only occasionally 
 
3. How many hours of do you spend in front of the television or computer 
every day? 
 
Less than 1 hour  
1 to 3 hours  
More than 3 hours to 5 hours  
    More than 5 hours  
 
 







5a. What is your smoking status? 
IF YOU ARE A “NON-SMOKER”, PLEASE SKIP TO SECTION VI 
IF YOU ARE A “SMOKER”, PLEASE ANSWER QUESTION 5b BELOW 




 5b. If you currently are a smoker, 
 How many years have you been smoking?    ______________   
 How many cigarettes do you smoke every day?   ______________ 
  
 5c. If you have already stopped smoking, 
  How many years has it been since you stopped smoking?  ______________ 
  For how many years did you use to smoke?    ______________ 
  How many cigarettes did you use to smoke every day?  ______________ 
 
 






1. Please state the number of people living in the household who smoke cigarettes, including parents: _________ 
 
2. Does your father (or male guardian) smoke cigarettes? Yes 
No 
If YES, please state the amount of cigerettes which your father (or male guardian) smoke each 
day: 
 Number of Cigarettes______ /day 
 
 
3. Does your mother (or female guardian) smoke cigarettes? Yes 
No 
If YES, please state the amount of cigarettes that your mother (or female guardian) smoke 
each day: 
 Number of Cigarettes______ /day 
 
 





5. Have you ever had animals (e.g. cats, dogs, mice, hamsters, etc) in your house? 
 





6. At what AGE did you have the following animals in your house? 
YOU CAN TICK MORE THAN ONE BOX 
 
       Age 
Animal 
< 2 2-6 7-12 13-18 >18 
Cat      
Dog      
Rodent (hamster, mouse, etc.)      
Birds (chicken, parrot, pigeon, etc.)      








Section VII  
 
1. What is the highest level of education completed by your mother?  
Primary Secondary (‘O’ or ‘A’ levels’)  Tertiary (Diploma, Degree or higher)  
2. What is the highest level of education completed by your father? 
Primary Secondary (‘O’ or ‘A’ levels’)  Tertiary (Diploma, Degree or higher)  
3a. Has your mother ever been diagnosed with 
 
Asthma Yes No Don’t know 
Allergic rhinitis (Hay fever) Yes No Don’t know 
Eczema (Sensitive Skin)  Yes No Don’t know 
 
3b. Any drug allergies? If any, please specify:____________________________________________ 
 
4a. Has your father ever been diagnosed with 
 
Asthma Yes No Don’t know 
Allergic rhinitis (Hay fever) Yes No Don’t know 
Eczema (Sensitive Skin)  Yes No Don’t know 
 
4b. Any drug allergies? If any, please specify:____________________________________________ 
 
5a. Please state the number of siblings that you have (excluding yourself): _________ 
5b. How many of your siblings have been diagnosed with the following? 
Asthma 0 1 2 3 or more Don’t Know 
Allergic rhinitis (Hay fever) 0 1 2 3 or more Don’t Know 




Thank you for taking the time to complete this questionnaire.   















SKIN PRICK TESTING PROTOCOL 
 
 
1. Prep the forearm with alcohol swab. 
2. Mark 6 spots on the forearm in two parallel rows 3cm apart with a ballpoint pen. 
3. Place 1.5 µl of each control and allergen extracts in the same format as listed in the table 
below 
4. Prick the skin below the extracts with a lancet. Change the lancet after each allergen. 
5. Wait for 15 minutes. 
6. Measure the longest and shortest diameter of the erythema (flare) and wheal (swelling) 
with a ruler and if pseudopodia is present, and note it in the table below. 
 
SKIN PRICK TEST RECORD 
TEST RESULTS 
(mm) 





E      x 




E      x 




E      x 




(oil palm pollen) 
E      x 





E      x 




E      x 
W     x 
 
 
RESULTS E: Erythema flare diameter  W: Wheal diameter 
CLASS 0= No wheal. Erythema absent or < 1mm diameter or reaction < control 
  1+ = Wheal absent or slight. Erythema present and < 3mm diameter 
  2+ = Wheal absent or slight with associated erythema > 3mm diameter 
  3+ = Wheal ≥ 3mm and with erythema 
  4+ = Wheal ≥ 3mm with pseudopodia and erythema 
